| Code | Display | Comments |
|---|
 100002-5 | Specimen care is maintained | |
| 100003-3 | Team communication is maintained throughout care | |
| 100004-1 | Demonstrates knowledge of the expected psychosocial responses to the procedure | |
| 100005-8 | Demonstrates knowledge of nutritional management related to the procedure | |
| 100006-6 | Demonstrates knowledge of medication management | |
| 100007-4 | Demonstrates knowledge of pain management | |
| 100008-2 | Demonstrates knowledge of wound management | |
| 100009-0 | Demonstrates knowledge of the procedure and expected results | |
| 100010-8 | No injury related to procedure equipment, medical supplies, or instrumentation | |
| 100011-6 | No injury related to an electrical source | |
| 100012-4 | Participates in decisions affecting the patient's plan of care | |
| 100013-2 | Participates in the discharge process | |
| 100014-0 | Psychosocial health is maintained at or improved from baseline | |
| 100015-7 | No injury related to positioning due to care or procedure | |
| 100016-5 | No injury related to a laser source | |
| 100017-3 | Perioperative nursing data set outcomes panel [PNDS] | |
| 100030-6 | Axis I: Temporal aspects score [Mainz Pain Staging System] | |
| 100031-4 | Axis II: Spatial aspects score [Mainz Pain Staging System] | |
| 100032-2 | Axis III: Drug taking behavior score [Mainz Pain Staging System] | |
| 100033-0 | Axis IV: Utilization of the health care system score [Mainz Pain Staging System] | |
| 100159-3 | Knee Society Score pre-op panel [Knee Society Score] | |
| 100168-4 | Knee pain severity with level walking | |
| 100169-2 | Knee pain severity with stairs or inclines | |
| 100170-0 | Knee feels normal | |
| 100171-8 | Satisfaction with level of knee pain while sitting | |
| 100172-6 | Satisfaction with level of knee pain while lying in bed | |
| 100173-4 | Satisfaction with knee function while getting out of bed | |
| 100174-2 | Satisfaction with knee function while performing light household duties | |
| 100175-9 | Satisfaction with knee function while performing recreational activities | |
| 100176-7 | Expect surgery to relieve pain | |
| 100177-5 | Expect surgery will improve ability to perform activities of daily living | |
| 100178-3 | Expect surgery will improve ability to perform leisure, recreational, or sports activities | |
| 100179-1 | Walk without assistive mobility devices | |
| 100180-9 | Assistive mobility devices used | |
| 100181-7 | Assistive mobility devices used due to health condition | |
| 100182-5 | Duration of standing before sitting due to knee discomfort | |
| 100183-3 | Duration of walking before stopping due to knee discomfort | |
| 100184-1 | How bothersome is knee when walking on an uneven surface | |
| 100185-8 | How bothersome is knee when turning or pivoting leg | |
| 100186-6 | How bothersome is knee when climbing up or down a flight of stairs | |
| 100187-4 | How bothersome is knee when getting up from a low seat without armrests | |
| 100188-2 | How bothersome is knee when getting into or out of a car | |
| 100189-0 | How bothersome is knee when moving laterally | |
| 100190-8 | How bothersome is knee when climbing a ladder or step stool | |
| 100191-6 | How bothersome is knee when carrying a bag for one block | |
| 100192-4 | How bothersome is knee when squatting | |
| 100193-2 | How bothersome is knee when kneeling | |
| 100194-0 | How bothersome is knee when running | |
| 100195-7 | Pain severity--during activity | |
| 100196-5 | Pre-op total score [Knee Society Score] | |
| 100197-3 | Exercise activity and pain severity panel | |
| 100198-1 | Pre-op objective knee indicators score [Knee Society Score] | |
| 100199-9 | Pre-op symptoms score [Knee Society Score] | |
| 100200-5 | Pre-op patient expectations score [Knee Society Score] | |
| 100201-3 | Pre-op functional activities score [Knee Society Score] | |
| 100202-1 | Pre-op discretionary knee activities score [Knee Society Score] | |
| 100203-9 | Knee Society Score post-op panel [Knee Society Score] | |
| 100204-7 | Accuracy of pre-surgery expectations of pain relief | |
| 100205-4 | Accuracy of pre-surgery expectations to perform activities of daily living | |
| 100206-2 | Accuracy of pre-surgery expectations to perform leisure, recreational, or sports activities | |
| 100207-0 | Post-op total score [Knee Society Score] | |
| 100208-8 | Post-op objective knee indicators score [Knee Society Score] | |
| 100209-6 | Post-op symptoms score [Knee Society Score] | |
| 100210-4 | Post-op patient expectations score [Knee Society Score] | |
| 100211-2 | Post-op functional activities score [Knee Society Score] | |
| 100212-0 | Post-op discretionary knee activities score [Knee Society Score] | |
| 100232-8 | Impacts of Events Scale-Revised panel | |
| 100233-6 | Reminders brought back feelings about adverse event | |
| 100234-4 | Trouble staying asleep | |
| 100235-1 | Other things triggered persistent thoughts about adverse event | |
| 100236-9 | Felt irritable AndOr angry | |
| 100237-7 | Avoided getting upset when unintentionally thought about adverse event | |
| 100238-5 | Thought about adverse event unintentionally | |
| 100239-3 | Felt as if adverse event did not happen | |
| 100240-1 | Avoided reminders of adverse event | |
| 100241-9 | Experienced mental images of adverse event | |
| 100242-7 | Easily startled | |
| 100243-5 | Tried to not think of adverse event | |
| 100244-3 | Aware of feelings about adverse event, but did not address them | |
| 100245-0 | Feelings about adverse event were numb | |
| 100246-8 | Acted or felt the same as during adverse event | |
| 100247-6 | Trouble falling asleep | |
| 100248-4 | Waves of strong feelings about adverse event | |
| 100249-2 | Tried to remove adverse event from memory | |
| 100250-0 | Trouble concentrating | |
| 100251-8 | Reminders of adverse event caused physical reactions | |
| 100252-6 | Had dreams about adverse event | |
| 100253-4 | Felt watchful and on-guard | |
| 100254-2 | Tried not to talk about adverse event | |
| 100255-9 | Total score [Impact of Event Scale-Revised] | |
| 100259-1 | Aware of tactile sensations | |
| 100260-9 | Easy to describe thoughts AndOr feelings | |
| 100261-7 | Critical of own thoughts AndOr feelings | |
| 100262-5 | Able to notice distressing thoughts AndOr feelings without having to react | |
| 100263-3 | Easily distracted | |
| 100264-1 | Able to notice thoughts AndOr feelings without being overwhelmed | |
| 100265-8 | Aware of dietary intake impact on self | |
| 100266-6 | Difficult to describe thoughts AndOr feelings | |
| 100267-4 | Aware of auditory stimuli | |
| 100268-2 | Able to avoid immediate reaction in difficult situations | |
| 100269-0 | Do things without paying attention | |
| 100270-8 | Recover quickly from distressing thoughts AndOr images | |
| 100271-6 | Aware of olfactory stimuli | |
| 100272-4 | Aware of visual stimuli | |
| 100273-2 | Aware of emotions affect on thoughts AndOr behavior | |
| 100274-0 | Observing score [FFMQ] | |
| 100275-7 | Describing score [FFMQ] | |
| 100276-5 | Acting with awareness score [FFMQ] | |
| 100277-3 | Nonjudging score [FFMQ] | |
| 100278-1 | Nonreactivity score [FFMQ] | |
| 100279-9 | Total score [FFMQ] | |
| 100280-7 | Five Facet Mindfulness Questionnaire panel [FFMQ] | |
| 100283-1 | Harris Hip Score panel [Harris Hip Score] | |
| 100284-9 | Walking - functional ability | |
| 100285-6 | Comfortable seated position | |
| 100286-4 | Able to board public transportation | |
| 100287-2 | Put on shoes and socks | |
| 100288-0 | Absence of deformity score [Harris Hip Score] | |
| 100289-8 | Absence of hip deformity measurements | |
| 100290-6 | Range of motion score [Harris Hip Score] | |
| 100291-4 | Total score [Harris Hip Score] | |
| 100292-2 | Pre-op patient satisfaction score [Knee Society Score] | |
| 100293-0 | Hip Flexion range of motion | |
| 100294-8 | Hip Abduction range of motion | |
| 100295-5 | Hip Adduction range of motion | |
| 100296-3 | Hip External rotation range of motion | |
| 100297-1 | Hip Internal rotation range of motion | |
| 100299-7 | Post-op patient satisfaction score [Knee Society Score] | |
| 100307-8 | Behavioral screening elder mistreatment | |
| 100308-6 | Need help getting to essential places | |
| 100309-4 | Activity support person | |
| 100310-2 | Reliability of support person | |
| 100311-0 | Need help to make sure there is enough food, medicines or any other things needed in house | |
| 100312-8 | Person or persons that makes sure there is enough food, medicines or any other things needed in house | |
| 100313-6 | Need help with household things such as cook meals, help feed, or provide correct medicines each day | |
| 100314-4 | Need help with house cleaning or yard work | |
| 100315-1 | Need help getting out of bed, showered, or dressed | |
| 100316-9 | Need help to make sure bills get paid | |
| 100317-7 | Relationship of usual support person for daily activities | |
| 100318-5 | Have help with finances AndOr financial decisions | |
| 100319-3 | Relationship of financial support person | |
| 100320-1 | Financial support person usually asks for permission before making decisions | |
| 100321-9 | Financial support person usually makes good decisions about finances | |
| 100322-7 | Have access to paperwork for financial decisions made | |
| 100323-5 | Financial support person forged signature | |
| 100324-3 | Coercion of financial support person for signing a document in order to get money or possessions | |
| 100325-0 | Experienced theft by support person | |
| 100326-8 | Money spent or property sold without permission | |
| 100327-6 | Stranger forged signature for financial gain | |
| 100328-4 | Stranger forced document signature for financial gain | |
| 100329-2 | Feared for safety due to verbal attack | |
| 100330-0 | Felt humiliated due to ridicule | |
| 100331-8 | Coerced to do something | |
| 100332-6 | Ignored by close friend or relative for extended period | |
| 100333-4 | Physically hit or threatened | |
| 100334-2 | Been physically hurt with some degree of injury | |
| 100335-9 | Coerced sexual activity | |
| 100336-7 | Coerced touching of private body parts of self or others | |
| 100337-5 | Coerced to undress or expose private body area | |
| 100338-3 | Photographed in any degree of nudity without consent | |
| 100339-1 | Experienced attempted physical restraint | |
| 100340-9 | Range of motion panel Hip | |
| 100353-2 | Norwalk Community Health Center Screening Tool [NCHC] | |
| 100354-0 | Frequency of participating in multi-modal communication without assistance | |
| 100355-7 | Frequency of participating in spoken language expression communication without assistance | |
| 100360-7 | Brief Resilience Scale panel [BRS] | |
| 100361-5 | Quickly recover from bad events | |
| 100362-3 | Difficulty making it through stressful events | |
| 100363-1 | Easily recover from a stressful event | |
| 100364-9 | Difficulty recovering from bad events | |
| 100365-6 | Easily recover from difficulties | |
| 100366-4 | Lengthy recovery from setbacks | |
| 100367-2 | Total Score BRS | |
| 100766-5 | Center for Epidemiologic Studies Depression Scale panel [CES-D] | |
| 100767-3 | Bothered by things that are not usually bothersome | |
| 100768-1 | Poor appetite | |
| 100769-9 | Unhappy even with help from my family or friends | |
| 100770-7 | Feeling just as good as others | |
| 100771-5 | Trouble focusing | |
| 100772-3 | Feeling depressed | |
| 100773-1 | Feeling everything is too much of an effort | |
| 100774-9 | Feeling hopeful about the future | |
| 100775-6 | Feeling life had been a failure | |
| 100776-4 | Feeling fearful | |
| 100777-2 | Restless sleep | |
| 100778-0 | Feeling happy | |
| 100779-8 | Quieter than usual | |
| 100780-6 | Feeling lonely | |
| 100781-4 | People were unfriendly | |
| 100782-2 | Enjoying life | |
| 100783-0 | Crying spells | |
| 100784-8 | Feeling sad | |
| 100785-5 | Feeling people dislike me | |
| 100786-3 | Lack of energy | |
| 100787-1 | Total Score CES-D | |
| 100916-6 | User satisfaction score [R-Outcomes] | | |
| 100917-4 | Product of interest effectiveness | | |
| 100918-2 | Product of interest usability | | |
| 100919-0 | Access to help with product of interest | | |
| 100920-8 | Satisfied with product of interest | | |
| 100921-6 | User satisfaction panel [R-Outcomes] | | |
| 100922-4 | Privacy panel [R-Outcomes] | | |
| 100923-2 | Privacy score [R-Outcomes] | | |
| 100924-0 | Safe and secure healthcare data | | |
| 100925-7 | Healthcare data exchanged as needed | | |
| 100926-5 | Access to review healthcare data | | |
| 100927-3 | Satisfied with healthcare data use | | |
| 100928-1 | Digital confidence panel [R-Outcomes] | | |
| 100929-9 | Digital confidence score [R-Outcomes] | | |
| 100930-7 | Digital device use | | |
| 100931-5 | Friends use digital devices | | |
| 100932-3 | Access to help with digital devices | | |
| 100933-1 | Confident using digital devices | | |
| 100934-9 | Personal safety panel [R-Outcomes] | | |
| 100935-6 | Personal safety score [R-Outcomes] | | |
| 100936-4 | Feel safe at home | | |
| 100937-2 | Feel respected at home | | |
| 100938-0 | Feel safe outside home | | |
| 100939-8 | Feel respected outside home | | |
| 100940-6 | Neighbor relationships panel [R-Outcomes] | | |
| 100941-4 | Neighbor relationships score [R-Outcomes] | | |
| 100942-2 | Neighbors and I know each other | | |
| 100943-0 | Neighbors and I trust each other | | |
| 100944-8 | Neighbors and I share information | | |
| 100945-5 | Neighbors and I help each other | | |
| 100946-3 | Loneliness (ONS) score | | |
| 100947-1 | Frequency of having no one to talk to | | |
| 100948-9 | Frequency of feeling left out | | |
| 100949-7 | Frequency of feeling alone | | |
| 100950-5 | Frequency of feeling lonely | | |
| 100951-3 | Loneliness Office of National Statistics panel | | |
| 100952-1 | Product confidence panel [R-Outcomes] | | |
| 100953-9 | Product confidence score [R-Outcomes] | | |
| 100954-7 | Product of interest use | | |
| 100955-4 | Confident using product of interest | | |
| 100956-2 | Understand potential benefits of product of interest | | |
| 100957-0 | Understand potential problems of product of interest | | |
| 100958-8 | Digital readiness panel [R-Outcomes] | | |
| 100959-6 | Digital readiness score [R-Outcomes] | | |
| 100960-4 | New ideas are needed in field of work | | |
| 100961-2 | Follow new ideas in field of work | | |
| 101104-8 | Minimum Data Set (MDS) - version 3.0 - Resident Assessment Instrument (RAI) version 1.18.11 [CMS Assessment] | | |
| 101105-5 | MDS v3.0 - RAI v1.18.11 - Nursing home comprehensive (NC) item set [CMS Assessment] | | |
| 101258-2 | MDS v3.0 - RAI v1.18.11 - Identification Information [CMS Assessment] | | |
| 101259-0 | MDS v3.0 - RAI v1.18.11 - Hearing, Speech, and Vision [CMS Assessment] | | |
| 101260-8 | MDS v3.0 - RAI v1.18.11 - Cognitive Patterns [CMS Assessment] | | |
| 101261-6 | MDS v3.0 - RAI v1.18.11 - Mood [CMS Assessment] | | |
| 101262-4 | MDS v3.0 - RAI v1.18.11 - Behavior [CMS Assessment] | | |
| 101263-2 | MDS v3.0 - RAI v1.18.11 - Preferences for Customary Routine and Activities [CMS Assessment] | | |
| 101264-0 | MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals [CMS Assessment] | | |
| 101265-7 | MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals - Admission [CMS Assessment] | | |
| 101266-5 | MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals - Discharge [CMS Assessment] | | |
| 101267-3 | MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals - OBRA/Interim [CMS Assessment] | | |
| 101268-1 | MDS v3.0 - RAI v1.18.11 - Bladder and Bowel [CMS Assessment] | | |
| 101269-9 | MDS v3.0 - RAI v1.18.11 - Active Diagnoses [CMS Assessment] | | |
| 101270-7 | MDS v3.0 - RAI v1.18.11 - Health Conditions [CMS Assessment] | | |
| 101271-5 | MDS v3.0 - RAI v1.18.11 - Swallowing/Nutritional Status [CMS Assessment] | | |
| 101272-3 | MDS v3.0 - RAI v1.18.11 - Oral/Dental Status [CMS Assessment] | | |
| 101273-1 | MDS v3.0 - RAI v1.18.11 - Skin Conditions [CMS Assessment] | | |
| 101274-9 | MDS v3.0 - RAI v1.18.11 - Medications [CMS Assessment] | | |
| 101275-6 | MDS v3.0 - RAI v1.18.11 - Header - Special Treatments, Procedures, and Programs [CMS Assessment] | | |
| 101276-4 | MDS v3.0 - RAI v1.18.11 - Restraints and Alarms [CMS Assessment] | | |
| 101277-2 | MDS v3.0 - RAI v1.18.11 - Header - Participation in Assessment and Goal Setting [CMS Assessment] | | |
| 101278-0 | MDS v3.0 - RAI v1.18.11 - Care Area Assessment (CAA) Summary [CMS Assessment] | | |
| 101279-8 | MDS v3.0 - RAI v1.18.11 - Correction Request [CMS Assessment] | | |
| 101280-6 | MDS v3.0 - RAI v1.18.11 - Assessment Administration [CMS Assessment] | | |
| 101321-8 | MDS v3.0 - RAI v1.18.11 - Self-Care - Admission Performance | | |
| 101322-6 | MDS v3.0 - RAI v1.18.11 - Self-Care - Discharge Goal | | |
| 101323-4 | MDS v3.0 - RAI v1.18.11 - Mobility - Admission Performance during assessment period [CMS Assessment] | | |
| 101324-2 | MDS v3.0 - RAI v1.18.11 - Mobility - Discharge Goal during assessment period [CMS Assessment] | | |
| 101325-9 | MDS v3.0 - RAI v1.18.11 - Tub/shower transfer - functional goal [CMS Assessment] | | |
| 101326-7 | MDS v3.0 - RAI v1.18.11 - Pain assessment interview during assessment period [CMS Assessment] | | |
| 101327-5 | MDS v3.0 - RAI v1.18.11 - Nutritional approaches - on admission during assessment period [CMS Assessment] | | |
| 101328-3 | MDS v3.0 - RAI v1.18.11 - Nutritional approaches - at discharge during assessment period [CMS Assessment] | | |
| 101329-1 | MDS v3.0 - RAI v1.18.11 - Participation in assessment and goal setting [CMS Assessment] | | |
| 101330-9 | MDS v3.0 - RAI v1.18.11 - Number of venous and arterial ulcers during assessment period [CMS Assessment] | | |
| 101331-7 | MDS v3.0 - RAI v1.18.11 - Ulcers, wounds and skin problems during assessment period [CMS Assessment] | | |
| 101332-5 | MDS v3.0 - RAI v1.18.11 - Reason referral to local contact agency not made [CMS Assessment] | | |
| 101333-3 | MDS v3.0 - RAI v1.18.11 - Determination of pressure injury risk [CMS Assessment] | | |
| 101337-4 | Treatment preferences under certain health conditions [Reported] | | |
| 101346-5 | MDS v3.0 - RAI v1.18.11 - Special Treatments, Procedures, and Programs [CMS Assessment] | | |
| 101347-3 | MDS v3.0 - RAI v1.18.11 - Return to community [CMS Assessment] | | |
| 101351-5 | Has lack of transportation kept you from medical appointments, meetings, work, or from getting things needed for daily living [CMS Assessment] | | |
| 101374-7 | MDS v3.0 - RAI v1.18.11 - Referral has been made to the local contact agency Patient education material [CMS Assessment] | | |
| 101429-9 | MDS v3.0 - RAI v1.18.11 - Self-care - discharge performance during assessment period [CMS Assessment] | | |
| 101430-7 | MDS v3.0 - RAI v1.18.11 - Self-Care - OBRA/Interim Performance | | |
| 101431-5 | MDS v3.0 - RAI v1.18.11 - Mobility - discharge performance [CMS Assessment] | | |
| 101432-3 | MDS v3.0 - RAI v1.18.11 - Mobility - OBRA/Interim Performance | | |
| 101435-6 | MDS v3.0 - RAI v1.18.11 - Referral [CMS Assessment] | | |
| 101436-4 | MDS v3.0 - RAI v1.18.11 - Discharge plan [CMS Assessment] | | |
| 28079-2 | Activities of daily living alteration [CCC] | | |
| 28080-0 | Activity alteration [CCC] | | |
| 28081-8 | Activity intolerance [CCC] | | |
| 28082-6 | Activity intolerance risk [CCC] | | |
| 28083-4 | Acute pain [CCC] | | |
| 28084-2 | Adjustment impairment [CCC] | | |
| 28085-9 | Airway clearance impairment [CCC] | | |
| 28086-7 | Decisional conflict [CCC] | | |
| 28087-5 | Defensive coping [CCC] | | |
| 28088-3 | Denial [CCC] | | |
| 28089-1 | Diarrhea [CCC] | | |
| 28090-9 | Disabled family coping Family [CCC] | | |
| 28091-7 | Disuse syndrome [CCC] | | |
| 28092-5 | Diversional activity deficit [CCC] | | |
| 28093-3 | Dressing/grooming deficit [CCC] | | |
| 28094-1 | Dying process [CCC] | | |
| 28095-8 | Dysfunctional grieving [CCC] | | |
| 28096-6 | Autonomic dysreflexia [CCC] | | |
| 28097-4 | Endocrine alteration [CCC] | | |
| 28098-2 | Family coping impairment Family [CCC] | | |
| 28099-0 | Family process alteration Family [CCC] | | |
| 28100-6 | Fatigue [CCC] | | |
| 28101-4 | Fear [CCC] | | |
| 28102-2 | Fecal impaction [CCC] | | |
| 28103-0 | Feeding deficit [CCC] | | |
| 28104-8 | Fluid volume alteration [CCC] | | |
| 28105-5 | Fluid volume deficit [CCC] | | |
| 28106-3 | Fluid volume deficit risk [CCC] | | |
| 28107-1 | Fluid volume excess [CCC] | | |
| 28108-9 | Fluid volume excess risk [CCC] | | |
| 28109-7 | Functional urinary incontinence [CCC] | | |
| 28110-5 | Gas exchange impairment [CCC] | | |
| 28111-3 | Gastrointestinal alteration [CCC] | | |
| 28112-1 | Grieving [CCC] | | |
| 28113-9 | Growth and development alteration [CCC] | | |
| 28114-7 | Gustatory alteration [CCC] | | |
| 28115-4 | Health maintenance alteration [CCC] | | |
| 28116-2 | Health-seeking behavior alteration [CCC] | | |
| 28117-0 | Home maintenance alteration [CCC] | | |
| 28118-8 | Hopelessness [CCC] | | |
| 28119-6 | Hypothermia [CCC] | | |
| 28120-4 | Hyperthermia [CCC] | | |
| 28121-2 | Immunologic alteration [CCC] | | |
| 28122-0 | Individual coping impairment [CCC] | | |
| 28123-8 | Infection risk [CCC] | | |
| 28124-6 | Infection [CCC] | | |
| 28125-3 | Injury risk [CCC] | | |
| 28126-1 | Instrumental activity of daily living (IADLS) alteration [CCC] | | |
| 28127-9 | Kinesthetic alteration [CCC] | | |
| 28128-7 | Knowledge deficit [CCC] | | |
| 28129-5 | Knowledge deficit of diagnostic test [CCC] | | |
| 28130-3 | Knowledge deficit of dietary regimen [CCC] | | |
| 28131-1 | Knowledge deficit of disease process [CCC] | | |
| 28132-9 | Knowledge deficit of fluid volume [CCC] | | |
| 28133-7 | Knowledge deficit of medication regimen [CCC] | | |
| 28134-5 | Anticipatory grieving [CCC] | | |
| 28135-2 | Anxiety [CCC] | | |
| 28136-0 | Aspiration risk [CCC] | | |
| 28137-8 | Auditory alteration [CCC] | | |
| 28138-6 | Bathing/hygiene deficit [CCC] | | |
| 28139-4 | Blood pressure alteration [CCC] | | |
| 28140-2 | Body image disturbance [CCC] | | |
| 28141-0 | Body nutrition deficit [CCC] | | |
| 28142-8 | Body nutrition deficit risk [CCC] | | |
| 28143-6 | Body nutrition excess [CCC] | | |
| 28144-4 | Body nutrition excess risk [CCC] | | |
| 28145-1 | Bowel elimination alteration [CCC] | | |
| 28146-9 | Bowel incontinence [CCC] | | |
| 28147-7 | Breastfeeding impairment [CCC] | | |
| 28148-5 | Breathing pattern impairment [CCC] | | |
| 28149-3 | Cardiac output alteration [CCC] | | |
| 28150-1 | Cardiovascular alteration [CCC] | | |
| 28151-9 | Cerebral alteration [CCC] | | |
| 28152-7 | Chronic low self-esteem disturbance [CCC] | | |
| 28153-5 | Chronic pain [CCC] | | |
| 28154-3 | Colonic constipation [CCC] | | |
| 28155-0 | Comfort alteration [CCC] | | |
| 28156-8 | Communication impairment [CCC] | | |
| 28157-6 | Compromised family coping Family [CCC] | | |
| 28158-4 | May choose to self-deliver at the end [Living with HIV] | | |
| 28159-2 | Meaningful life [Living with HIV] | | |
| 28160-0 | Medications are taking over my life [Living with HIV] | | |
| 28161-8 | Need help letting go [Living with HIV] | | |
| 28162-6 | No energy to fight back [Living with HIV] | | |
| 28163-4 | Not enjoying life [Living with HIV] | | |
| 28164-2 | Pain is hard to manage [Living with HIV] | | |
| 28165-9 | So many things yet undone [Living with HIV] | | |
| 28166-7 | Somewhat disconnected [Living with HIV] | | |
| 28167-5 | Stay at home and receive treatment [Living with HIV] | | |
| 28168-3 | Take time for important things [Living with HIV] | | |
| 28169-1 | Use time wisely [Living with HIV] | | |
| 28170-9 | Want to die at home [Living with HIV] | | |
| 28171-7 | Knowledge deficit of safety precautions [CCC] | | |
| 28172-5 | Knowledge deficit of therapeutic regimen [CCC] | | |
| 28173-3 | Meaningfulness alteration [CCC] | | |
| 28174-1 | Medication risk [CCC] | | |
| 28175-8 | Musculoskeletal alteration [CCC] | | |
| 28176-6 | Noncompliance [CCC] | | |
| 28177-4 | Noncompliance with diagnostic test [CCC] | | |
| 28178-2 | Noncompliance with dietary regimen [CCC] | | |
| 28179-0 | Noncompliance with safety precautions [CCC] | | |
| 28180-8 | Noncompliance with therapeutic regimen [CCC] | | |
| 28181-6 | Nutrition alteration [CCC] | | |
| 28182-4 | Olfactory alteration [CCC] | | |
| 28183-2 | Oral mucous membranes impairment [CCC] | | |
| 28184-0 | Parental role conflict [CCC] | | |
| 28185-7 | Parenting alteration [CCC] | | |
| 28186-5 | Perceived constipation [CCC] | | |
| 28187-3 | Peripheral alteration [CCC] | | |
| 28188-1 | Personal identity disturbance [CCC] | | |
| 28189-9 | Physical mobility impairment [CCC] | | |
| 28190-7 | Physical regulation alteration [CCC] | | |
| 28191-5 | Poisoning risk [CCC] | | |
| 28192-3 | Polypharmacy [CCC] | | |
| 28193-1 | Post-trauma response [CCC] | | |
| 28194-9 | Powerlessness [CCC] | | |
| 28195-6 | Protection alteration [CCC] | | |
| 28196-4 | Rape trauma syndrome [CCC] | | |
| 28197-2 | Reflex urinary incontinence [CCC] | | |
| 28198-0 | Renal alteration [CCC] | | |
| 28199-8 | Respiration alteration [CCC] | | |
| 28200-4 | Role performance alteration [CCC] | | |
| 28201-2 | Self-care deficit [CCC] | | |
| 28202-0 | Self-concept alteration [CCC] | | |
| 28203-8 | Sensory perceptual alteration [CCC] | | |
| 28204-6 | Sexual dysfunction [CCC] | | |
| 28205-3 | Sexuality patterns alteration [CCC] | | |
| 28206-1 | Situational self-esteem disturbance [CCC] | | |
| 28207-9 | Skin incision [CCC] | | |
| 28208-7 | Skin integrity impairment [CCC] | | |
| 28209-5 | Skin integrity impairment risk [CCC] | | |
| 28210-3 | Sleep pattern disturbance [CCC] | | |
| 28211-1 | Social interaction alteration [CCC] | | |
| 28212-9 | Social isolation [CCC] | | |
| 28213-7 | Spiritual distress [CCC] | | |
| 28214-5 | Spiritual state alteration [CCC] | | |
| 28215-2 | Stress urinary incontinence [CCC] | | |
| 28216-0 | Suffocation risk [CCC] | | |
| 28217-8 | Sanitation Behavior Family [OMAHA] | | |
| 28218-6 | Sanitation Knowledge Family [OMAHA] | | |
| 28219-4 | Sanitation Status Family [OMAHA] | | |
| 28220-2 | Residence Behavior Family [OMAHA] | | |
| 28221-0 | Residence Knowledge Family [OMAHA] | | |
| 28222-8 | Residence Status Family [OMAHA] | | |
| 28223-6 | Neighborhood/workplace safety.behavior Family [OMAHA] | | |
| 28224-4 | Neighborhood/workplace safety..knowledge Family [OMAHA] | | |
| 28225-1 | Neighborhood/workplace safety.status Family [OMAHA] | | |
| 28226-9 | Swallowing impairment [CCC] | | |
| 28227-7 | Tactile alteration [CCC] | | |
| 28228-5 | Thermoregulation impairment [CCC] | | |
| 28229-3 | Thought process alteration [CCC] | | |
| 28230-1 | Tissue perfusion alteration [CCC] | | |
| 28231-9 | Toileting deficit [CCC] | | |
| 28232-7 | Total urinary incontinence [CCC] | | |
| 28233-5 | Trauma risk [CCC] | | |
| 28234-3 | Unilateral neglect [CCC] | | |
| 28235-0 | Constipation [CCC] | | |
| 28236-8 | Pain [CCC] | | |
| 28237-6 | Urge urinary incontinence [CCC] | | |
| 28238-4 | Urinary elimination alteration [CCC] | | |
| 28239-2 | Urinary retention [CCC] | | |
| 28240-0 | Verbal impairment [CCC] | | |
| 28241-8 | Violence risk [CCC] | | |
| 28242-6 | Visual alteration [CCC] | | |
| 28243-4 | Abuse Behavior [OMAHA] | | |
| 28244-2 | Abuse Knowledge [OMAHA] | | |
| 28245-9 | Abuse Status [OMAHA] | | |
| 28246-7 | Antepartum/postpartum.behavior [OMAHA] | | |
| 28247-5 | Antepartum/postpartum.status [OMAHA] | | |
| 28248-3 | Bowel Function Behavior [OMAHA] | | |
| 28249-1 | Bowel Function Knowledge [OMAHA] | | |
| 28250-9 | Bowel Function Status [OMAHA] | | |
| 28251-7 | Caretaking/parenting.behavior [OMAHA] | | |
| 28252-5 | Caretaking/parenting.knowledge [OMAHA] | | |
| 28253-3 | Caretaking/parenting.status [OMAHA] | | |
| 28254-1 | Circulation Behavior [OMAHA] | | |
| 28255-8 | Circulation Knowledge [OMAHA] | | |
| 28256-6 | Circulation Status [OMAHA] | | |
| 28257-4 | Cognition Behavior [OMAHA] | | |
| 28258-2 | Cognition Knowledge [OMAHA] | | |
| 28259-0 | Cognition Status [OMAHA] | | |
| 28260-8 | Communication With Community Resources Behavior [OMAHA] | | |
| 28261-6 | Communication With Community Resources Knowledge [OMAHA] | | |
| 28262-4 | Communication With Community Resources Status [OMAHA] | | |
| 28263-2 | Consciousness Behavior [OMAHA] | | |
| 28264-0 | Consciousness Knowledge [OMAHA] | | |
| 28265-7 | Consciousness Status [OMAHA] | | |
| 28266-5 | Dentition.behavior [OMAHA] | | |
| 28267-3 | Dentition.knowledge [OMAHA] | | |
| 28268-1 | Dentition.status [OMAHA] | | |
| 28269-9 | Digestion-hydration Behavior [OMAHA] | | |
| 28270-7 | Digestion-hydration Knowledge [OMAHA] | | |
| 28271-5 | Digestion-hydration Status [OMAHA] | | |
| 28272-3 | Mental Health Behavior [OMAHA] | | |
| 28273-1 | Mental Health Knowledge [OMAHA] | | |
| 28274-9 | Mental Health Status [OMAHA] | | |
| 28275-6 | Family Planning Behavior [OMAHA] | | |
| 28276-4 | Family Planning Knowledge [OMAHA] | | |
| 28277-2 | Family Planning Status [OMAHA] | | |
| 28278-0 | Genito-urinary function.behavior [OMAHA] | | |
| 28279-8 | Genito-urinary function.knowledge [OMAHA] | | |
| 28280-6 | Genito-urinary function.status [OMAHA] | | |
| 28281-4 | Grief Behavior [OMAHA] | | |
| 28282-2 | Grief Knowledge [OMAHA] | | |
| 28283-0 | Grief Status [OMAHA] | | |
| 28284-8 | Growth And Development Behavior [OMAHA] | | |
| 28285-5 | Growth And Development Knowledge [OMAHA] | | |
| 28286-3 | Growth And Development Status [OMAHA] | | |
| 28287-1 | Health Care Supervision Behavior [OMAHA] | | |
| 28288-9 | Health Care Supervision Knowledge [OMAHA] | | |
| 28289-7 | Health Care Supervision Status [OMAHA] | | |
| 28290-5 | Hearing Behavior [OMAHA] | | |
| 28291-3 | Hearing Knowledge [OMAHA] | | |
| 28292-1 | Hearing Status [OMAHA] | | |
| 28293-9 | Sexuality Behavior [OMAHA] | | |
| 28294-7 | Sexuality Knowledge [OMAHA] | | |
| 28295-4 | Sexuality Status [OMAHA] | | |
| 28296-2 | Income Behavior [OMAHA] | | |
| 28297-0 | Income Knowledge [OMAHA] | | |
| 28298-8 | Income Status [OMAHA] | | |
| 28299-6 | Skin Behavior [OMAHA] | | |
| 28300-2 | Skin Knowledge [OMAHA] | | |
| 28301-0 | Skin Status [OMAHA] | | |
| 28302-8 | Interpersonal Relationship Behavior [OMAHA] | | |
| 28303-6 | Interpersonal Relationship Knowledge [OMAHA] | | |
| 28304-4 | Interpersonal Relationship Status [OMAHA] | | |
| 28305-1 | Neglect Behavior [OMAHA] | | |
| 28306-9 | Neglect Knowledge [OMAHA] | | |
| 28307-7 | Neglect Status [OMAHA] | | |
| 28308-5 | Neighborhood/workplace safety.behavior [OMAHA] | | |
| 28309-3 | Neighborhood/workplace safety..knowledge [OMAHA] | | |
| 28310-1 | Neighborhood/workplace safety.status [OMAHA] | | |
| 28311-9 | Neuro-musculo-skeletal Function Behavior [OMAHA] | | |
| 28312-7 | Neuro-musculo-skeletal Function Knowledge [OMAHA] | | |
| 28313-5 | Neuro-musculo-skeletal Function Status [OMAHA] | | |
| 28314-3 | Nutrition Behavior [OMAHA] | | |
| 28315-0 | Nutrition Knowledge [OMAHA] | | |
| 28316-8 | Nutrition Status [OMAHA] | | |
| 28317-6 | Pain Behavior [OMAHA] | | |
| 28318-4 | Pain Knowledge [OMAHA] | | |
| 28319-2 | Pain Status [OMAHA] | | |
| 28320-0 | Personal Care Behavior [OMAHA] | | |
| 28321-8 | Personal Care Knowledge [OMAHA] | | |
| 28322-6 | Personal Care Status [OMAHA] | | |
| 28323-4 | Physical Activity Behavior [OMAHA] | | |
| 28324-2 | Physical Activity Knowledge [OMAHA] | | |
| 28325-9 | Physical Activity Status [OMAHA] | | |
| 28326-7 | Medication Regimen Behavior [OMAHA] | | |
| 28327-5 | Medication Regimen Knowledge [OMAHA] | | |
| 28328-3 | Medication Regimen Status [OMAHA] | | |
| 28329-1 | Residence Behavior [OMAHA] | | |
| 28330-9 | Residence Knowledge [OMAHA] | | |
| 28331-7 | Residence Status [OMAHA] | | |
| 28332-5 | Respiration Behavior [OMAHA] | | |
| 28333-3 | Respiration Knowledge [OMAHA] | | |
| 28334-1 | Respiration Status [OMAHA] | | |
| 28335-8 | Role Change Behavior [OMAHA] | | |
| 28336-6 | Role Change Knowledge [OMAHA] | | |
| 28337-4 | Role Change Status [OMAHA] | | |
| 28338-2 | Sanitation Behavior [OMAHA] | | |
| 28339-0 | Sanitation Knowledge [OMAHA] | | |
| 28340-8 | Sanitation Status [OMAHA] | | |
| 28341-6 | Sleep And Rest Pattern Behavior [OMAHA] | | |
| 28342-4 | Sleep And Rest Pattern Knowledge [OMAHA] | | |
| 28343-2 | Sleep And Rest Pattern Status [OMAHA] | | |
| 28344-0 | Social Contact Behavior [OMAHA] | | |
| 28345-7 | Social Contact Knowledge [OMAHA] | | |
| 28346-5 | Social Contact Status [OMAHA] | | |
| 28347-3 | Speech And Language Behavior [OMAHA] | | |
| 28348-1 | Speech And Language Knowledge [OMAHA] | | |
| 28349-9 | Speech And Language Status [OMAHA] | | |
| 28350-7 | Spirituality Behavior [OMAHA] | | |
| 28351-5 | Spirituality Knowledge [OMAHA] | | |
| 28352-3 | Spirituality Status [OMAHA] | | |
| 28353-1 | Substance Use Behavior [OMAHA] | | |
| 28354-9 | Substance Use Knowledge [OMAHA] | | |
| 28355-6 | Substance Use Status [OMAHA] | | |
| 28356-4 | Technical procedure.behavior [OMAHA] | | |
| 28357-2 | Technical procedure.knowledge [OMAHA] | | |
| 28358-0 | Technical procedure.status [OMAHA] | | |
| 28359-8 | Vision Behavior [OMAHA] | | |
| 28360-6 | Vision Knowledge [OMAHA] | | |
| 28361-4 | Vision Status [OMAHA] | | |
| 28362-2 | Anxiety [QAM] | | |
| 28363-0 | Fear [QAM] | | |
| 28364-8 | Afraid of pain and suffering [Living with HIV] | | |
| 28365-5 | Afraid to die [Living with HIV] | | |
| 28366-3 | Comfortable and well cared for [Living with HIV] | | |
| 28367-1 | Don't want high technology to keep me alive [Living with HIV] | | |
| 28368-9 | Don't have to keep fighting [Living with HIV] | | |
| 28369-7 | Embarrassed by the way I look [Living with HIV] | | |
| 28370-5 | Extra effort to do things [Living with HIV] | | |
| 28371-3 | Feel spiritual as I near the end [Living with HIV] | | |
| 28372-1 | Financial situation is distressing [Living with HIV] | | |
| 28373-9 | Frightened over little control [Living with HIV] | | |
| 28374-7 | Giving up things [Living with HIV] | | |
| 28375-4 | Anxiety [HIV-SSC] | | |
| 28376-2 | Chills [HIV-SSC] | | |
| 28377-0 | Day sweats [HIV-SSC] | | |
| 28378-8 | Depression [HIV-SSC] | | |
| 28379-6 | Diarrhea [HIV-SSC] | | |
| 28380-4 | Difficulty concentrating [HIV-SSC] | | |
| 28381-2 | Disorientation [HIV-SSC] | | |
| 28382-0 | Dry mouth [HIV-SSC] | | |
| 28383-8 | Fatigue [HIV-SSC] | | |
| 28384-6 | Fear [HIV-SSC] | | |
| 28385-3 | Fever [HIV-SSC] | | |
| 28386-1 | Gas /bloating [HIV-SSC] | | |
| 28387-9 | Lack of appetite [HIV-SSC] | | |
| 28388-7 | Loose stools [HIV-SSC] | | |
| 28389-5 | Memory loss [HIV-SSC] | | |
| 28390-3 | Muscle aches [HIV-SSC] | | |
| 28391-1 | Nausea [HIV-SSC] | | |
| 28392-9 | Night sweats [HIV-SSC] | | |
| 28393-7 | Painful joints [HIV-SSC] | | |
| 28394-5 | Shortness of breath at rest [HIV-SSC] | | |
| 28395-2 | Shortness of breath with activity [HIV-SSC] | | |
| 28396-0 | Thirsty [HIV-SSC] | | |
| 28397-8 | Vomiting [HIV-SSC] | | |
| 28398-6 | Weakness [HIV-SSC] | | |
| 28399-4 | Wheezing [HIV-SSC] | | |
| 28400-0 | I live for today [Living with HIV] | | |
| 28401-8 | Important to be in charge [Living with HIV] | | |
| 28402-6 | Important to be surrounded by those I love [Living with HIV] | | |
| 28403-4 | Independence [Living with HIV] | | |
| 28404-2 | Live life day to day [Living with HIV] | | |
| 28405-9 | Losing my looks is devastating [Living with HIV] | | |
| 28406-7 | Loss of independence [Living with HIV] | | |
| 28407-5 | Lots of regrets [Living with HIV] | | |
| 28408-3 | Toileting [QAM] | | |
| 28409-1 | Dressing [QAM] | | |
| 28410-9 | Grooming [QAM] | | |
| 28411-7 | Personal hygiene [QAM] | | |
| 28412-5 | Physical performance [QAM] | | |
| 28413-3 | Ambulation [QAM] | | |
| 28414-1 | Activity [QAM] | | |
| 28415-8 | Communication With Community Resources Behavior Family [OMAHA] | | |
| 28416-6 | Communication With Community Resources Knowledge Family [OMAHA] | | |
| 28417-4 | Communication With Community Resources Status Family [OMAHA] | | |
| 28418-2 | Social Contact Behavior Family [OMAHA] | | |
| 28419-0 | Social Contact Knowledge Family [OMAHA] | | |
| 28420-8 | Social Contact Status Family [OMAHA] | | |
| 28421-6 | Role Change Behavior Family [OMAHA] | | |
| 28422-4 | Role Change Knowledge Family [OMAHA] | | |
| 28423-2 | Role Change Status Family [OMAHA] | | |
| 28424-0 | Interpersonal Relationship Knowledge Family [OMAHA] | | |
| 28425-7 | Interpersonal Relationship Status Family [OMAHA] | | |
| 28426-5 | Neglect Behavior Family [OMAHA] | | |
| 28427-3 | Spirituality Behavior Family [OMAHA] | | |
| 28428-1 | Spirituality Knowledge Family [OMAHA] | | |
| 28429-9 | Spirituality Status Family [OMAHA] | | |
| 28430-7 | Grief Behavior Family [OMAHA] | | |
| 28431-5 | Grief Knowledge Family [OMAHA] | | |
| 28432-3 | Grief Status Family [OMAHA] | | |
| 28433-1 | Mental Health Behavior Family [OMAHA] | | |
| 28434-9 | Mental Health Knowledge Family [OMAHA] | | |
| 28435-6 | Mental Health Status Family [OMAHA] | | |
| 28436-4 | Sexuality Behavior Family [OMAHA] | | |
| 28437-2 | Sexuality Knowledge Family [OMAHA] | | |
| 28438-0 | Sexuality Status Family [OMAHA] | | |
| 28439-8 | Interpersonal Relationship Behavior Family [OMAHA] | | |
| 28440-6 | Caretaking/parenting.behavior Family [OMAHA] | | |
| 28441-4 | Caretaking/parenting.knowledge Family [OMAHA] | | |
| 28442-2 | Caretaking/parenting.status Family [OMAHA] | | |
| 28443-0 | Neglect Knowledge Family [OMAHA] | | |
| 28444-8 | Neglect Status Family [OMAHA] | | |
| 28445-5 | Abuse Behavior Family [OMAHA] | | |
| 28446-3 | Abuse Knowledge Family [OMAHA] | | |
| 28447-1 | Abuse Status Family [OMAHA] | | |
| 28448-9 | Growth And Development Behavior Family [OMAHA] | | |
| 28449-7 | Growth And Development Knowledge Family [OMAHA] | | |
| 28450-5 | Growth And Development Status Family [OMAHA] | | |
| 28451-3 | Hearing Behavior Family [OMAHA] | | |
| 28452-1 | Hearing Status Family [OMAHA] | | |
| 28453-9 | Vision Behavior Family [OMAHA] | | |
| 28454-7 | Vision Knowledge Family [OMAHA] | | |
| 28455-4 | Vision Status Family [OMAHA] | | |
| 28456-2 | Speech And Language Behavior Family [OMAHA] | | |
| 28457-0 | Speech And Language Knowledge Family [OMAHA] | | |
| 28458-8 | Speech And Language Status Family [OMAHA] | | |
| 28459-6 | Dentition.behavior Family [OMAHA] | | |
| 28460-4 | Dentition.knowledge Family [OMAHA] | | |
| 28461-2 | Dentition.status Family [OMAHA] | | |
| 28462-0 | Cognition Behavior Family [OMAHA] | | |
| 28463-8 | Cognition Knowledge Family [OMAHA] | | |
| 28464-6 | Cognition Status Family [OMAHA] | | |
| 28465-3 | Pain Behavior Family [OMAHA] | | |
| 28466-1 | Pain Knowledge Family [OMAHA] | | |
| 28467-9 | Pain Status Family [OMAHA] | | |
| 28468-7 | Consciousness Behavior Family [OMAHA] | | |
| 28469-5 | Consciousness Knowledge Family [OMAHA] | | |
| 28470-3 | Consciousness Status Family [OMAHA] | | |
| 28471-1 | Skin Behavior Family [OMAHA] | | |
| 28472-9 | Skin Knowledge Family [OMAHA] | | |
| 28473-7 | Skin Status Family [OMAHA] | | |
| 28474-5 | Neuro-musculo-skeletal Function Behavior Family [OMAHA] | | |
| 28475-2 | Neuro-musculo-skeletal Function Knowledge Family [OMAHA] | | |
| 28476-0 | Neuro-musculo-skeletal Function Status Family [OMAHA] | | |
| 28477-8 | Respiration Behavior Family [OMAHA] | | |
| 28478-6 | Respiration Knowledge Family [OMAHA] | | |
| 28479-4 | Respiration Status Family [OMAHA] | | |
| 28480-2 | Circulation Behavior Family [OMAHA] | | |
| 28481-0 | Circulation Knowledge Family [OMAHA] | | |
| 28482-8 | Circulation Status Family [OMAHA] | | |
| 28483-6 | Digestion-hydration Behavior Family [OMAHA] | | |
| 28484-4 | Digestion-hydration Knowledge Family [OMAHA] | | |
| 28485-1 | Digestion-hydration Status Family [OMAHA] | | |
| 28486-9 | Bowel Function Behavior Family [OMAHA] | | |
| 28487-7 | Bowel Function Knowledge Family [OMAHA] | | |
| 28488-5 | Bowel Function Status Family [OMAHA] | | |
| 28489-3 | Genito-urinary function.behavior Family [OMAHA] | | |
| 28490-1 | Genito-urinary function.knowledge Family [OMAHA] | | |
| 28491-9 | Genito-urinary function.status Family [OMAHA] | | |
| 28492-7 | Antepartum/postpartum.behavior Family [OMAHA] | | |
| 28493-5 | Antepartum/postpartum.status Family [OMAHA] | | |
| 28494-3 | Antepartum/postpartum.knowledge Family [OMAHA] | | |
| 28495-0 | Nutrition Behavior Family [OMAHA] | | |
| 28496-8 | Nutrition Knowledge Family [OMAHA] | | |
| 28497-6 | Nutrition Status Family [OMAHA] | | |
| 28498-4 | Sleep And Rest Pattern Behavior Family [OMAHA] | | |
| 28499-2 | Sleep And Rest Pattern Knowledge Family [OMAHA] | | |
| 28500-7 | Sleep And Rest Pattern Status Family [OMAHA] | | |
| 28501-5 | Physical Activity Behavior Family [OMAHA] | | |
| 28502-3 | Physical Activity Knowledge Family [OMAHA] | | |
| 28503-1 | Physical Activity Status Family [OMAHA] | | |
| 28504-9 | Personal Care Behavior Family [OMAHA] | | |
| 28505-6 | Personal Care Knowledge Family [OMAHA] | | |
| 28506-4 | Personal Care Status Family [OMAHA] | | |
| 28507-2 | Substance Use Behavior Family [OMAHA] | | |
| 28508-0 | Substance Use Knowledge Family [OMAHA] | | |
| 28509-8 | Substance Use Status Family [OMAHA] | | |
| 28510-6 | Family Planning Behavior Family [OMAHA] | | |
| 28511-4 | Family Planning Knowledge Family [OMAHA] | | |
| 28512-2 | Family Planning Status Family [OMAHA] | | |
| 28513-0 | Health Care Supervision Behavior Family [OMAHA] | | |
| 28514-8 | Health Care Supervision Knowledge Family [OMAHA] | | |
| 28515-5 | Health Care Supervision Status Family [OMAHA] | | |
| 28516-3 | Medication Regimen Behavior Family [OMAHA] | | |
| 28517-1 | Medication Regimen Knowledge Family [OMAHA] | | |
| 28518-9 | Medication Regimen Status Family [OMAHA] | | |
| 28519-7 | Technical procedure.behavior Family [OMAHA] | | |
| 28520-5 | Technical procedure.knowledge Family [OMAHA] | | |
| 28521-3 | Technical procedure.status Family [OMAHA] | | |
| 28522-1 | Income Status Family [OMAHA] | | |
| 28523-9 | Noncompliance with fluid volume [CCC] | | |
| 28524-7 | Noncompliance with medication regimen [CCC] | | |
| 28525-4 | Socialization alteration [CCC] | | |
| 28526-2 | Skin integrity alteration [CCC] | | |
| 28527-0 | Family embarrassed [Living with HIV] | | |
| 28528-8 | No good church experience [Living with HIV] | | |
| 28529-6 | Strength from family [Living with HIV] | | |
| 28530-4 | Family does what needs done [Living with HIV] | | |
| 28531-2 | My hometown means a lot [Living with HIV] | | |
| 28532-0 | No purpose in life [Living with HIV] | | |
| 28533-8 | Antepartum/postpartum.knowledge [OMAHA] | | |
| 28534-6 | Bathing [QAM] | | |
| 28535-3 | Income Knowledge Family [OMAHA] | | |
| 28536-1 | Income Behavior Family [OMAHA] | | |
| 28537-9 | Hearing Knowledge Family [OMAHA] | | |
| 28538-7 | Abdominal pain [HIV-SSC] | | |
| 42819-3 | Failure to thrive [CCC] | | |
| 42820-1 | Intracranial adaptive capacity impairment [CCC] | | |
| 42821-9 | Caregiver role strain Caregiver [CCC] | | |
| 42822-7 | Relocation stress syndrome [CCC] | | |
| 42823-5 | Suicide risk [CCC] | | |
| 42824-3 | Self mutilation risk [CCC] | | |
| 42825-0 | Perioperative injury risk [CCC] | | |
| 42826-8 | Perioperative positioning injury [CCC] | | |
| 42827-6 | Surgical recovery delay [CCC] | | |
| 42828-4 | Substance abuse [CCC] | | |
| 42829-2 | Tobacco abuse [CCC] | | |
| 42830-0 | Alcohol abuse [CCC] | | |
| 42831-8 | Drug abuse [CCC] | | |
| 42832-6 | Latex allergy response [CCC] | | |
| 42833-4 | Reproductive risk [CCC] | | |
| 42834-2 | Fertility risk [CCC] | | |
| 42835-9 | Infertility risk [CCC] | | |
| 42836-7 | Contraception risk [CCC] | | |
| 42837-5 | Perinatal risk [CCC] | | |
| 42838-3 | Pregnancy risk [CCC] | | |
| 42839-1 | Labor risk [CCC] | | |
| 42840-9 | Delivery risk [CCC] | | |
| 42841-7 | Postpartum risk [CCC] | | |
| 42842-5 | Newborn behavior alteration [CCC] | | |
| 42843-3 | Infant behavior alteration [CCC] | | |
| 42844-1 | Child behavior alteration [CCC] | | |
| 42845-8 | Adolescent behavior alteration [CCC] | | |
| 42846-6 | Adult behavior alteration [CCC] | | |
| 42847-4 | Sleep deprivation [CCC] | | |
| 42848-2 | Nausea [CCC] | | |
| 42849-0 | Confusion [CCC] | | |
| 42850-8 | Memory impairment [CCC] | | |
| 42851-6 | Infant feeding pattern impairment [CCC] | | |
| 42852-4 | Older adult behavior alteration.sixty five years and older [CCC] | | |
| 42853-2 | Ventilatory weaning impairment [CCC] | | |
| 42854-0 | Community coping impairment Community [CCC] | | |
| 44249-1 | PHQ-9 quick depression assessment panel [Reported.PHQ] | | |
| 44250-9 | Little interest or pleasure in doing things in last 2 weeks | | |
| 44251-7 | Poor appetite or overeating in last 2 weeks [Reported.PHQ] | | |
| 44252-5 | Trouble concentrating on things, such as reading the newspaper or watching television in last 2 weeks [Reported.PHQ] | | |
| 44253-3 | Moving or speaking so slowly that other people could have noticed. Or the opposite - being so fidgety or restless that you have been moving around a lot more than usual in last 2 weeks [Reported.PHQ] | | |
| 44254-1 | Feeling tired or having little energy in last 2 weeks [Reported.PHQ] | | |
| 44255-8 | Feeling down, depressed, or hopeless in last 2 weeks | | |
| 44256-6 | Perceived difficulty in last 2 weeks [Reported.PHQ] | | |
| 44257-4 | Deprecated Patient Health Questionnaire 9 item (PHQ-9) [Reported] | | |
| 44258-2 | Feeling bad about yourself - or that you are a failure or have let yourself or your family down in last 2 weeks [Reported.PHQ] | | |
| 44259-0 | Trouble falling or staying asleep, or sleeping too much in last 2 weeks [Reported.PHQ] | | |
| 44260-8 | Thoughts that you would be better off dead, or of hurting yourself in some way in last 2 weeks [Reported.PHQ] | | |
| 44261-6 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | | |
| 44262-4 | Deprecated PHQ-9 interpretation | | |
| 45399-3 | Federal provider number Facility | | |
| 45405-8 | Ability to understand others [Minimum Data Set] | | |
| 45406-6 | Change in communication/hearing [Minimum Data Set] | | |
| 45407-4 | Vision [Minimum Data Set] | | |
| 45408-2 | Primary reason for assessment [Minimum Data Set (MDS) basic] | | |
| 45409-0 | Codes for assessments required for Medicare PPS or the State [Minimum Data Set] | | |
| 45410-8 | Admitted from (at entry) Facility [Minimum Data Set] | | |
| 45411-6 | Lived alone prior to admission [Minimum Data Set] | | |
| 45412-4 | History of prior stay at this nursing home [Minimum Data Set] | | |
| 45413-2 | History of stay in other nursing home [Minimum Data Set] | | |
| 45414-0 | History of stay in other residential facility [Minimum Data Set] | | |
| 45415-7 | History of stay at mental health/psychiatric setting [Minimum Data Set] | | |
| 45416-5 | History of stay in mental retardation and developmental disabilities setting [Minimum Data Set] | | |
| 45417-3 | None of the listed prior residential settings [Minimum Data Set] | | |
| 45418-1 | Deprecated Lifetime occupations [CMS Assessment] | | |
| 45419-9 | Language.other [Minimum Data Set] | | |
| 45420-7 | Mental health history [Minimum Data Set] | | |
| 45421-5 | No mental retardation and developmental disabilities [Minimum Data Set] | | |
| 45422-3 | Down's syndrome [Minimum Data Set] | | |
| 45423-1 | Autism [Minimum Data Set] | | |
| 45424-9 | Epilepsy [Minimum Data Set] | | |
| 45425-6 | Other organic condition related to mental retardation and developmental disabilities [Minimum Data Set] | | |
| 45426-4 | Mental retardation and developmental disabilities with no organic condition [Minimum Data Set] | | |
| 45427-2 | Date background information form completed [Minimum Data Set] | | |
| 45428-0 | Stays up late at night [Minimum Data Set] | | |
| 45429-8 | Naps regularly during day [Minimum Data Set] | | |
| 45430-6 | Goes out 1 or more days a week [Minimum Data Set] | | |
| 45431-4 | Stays busy with hobbies, reading or fixed daily routine [Minimum Data Set] | | |
| 45432-2 | Spends most time alone or watching TV [Minimum Data Set] | | |
| 45433-0 | Moves independently indoors [Minimum Data Set] | | |
| 45434-8 | Use of tobacco products at least daily [Minimum Data Set] | | |
| 45435-5 | None of the listed cycle of daily events [Minimum Data Set] | | |
| 45436-3 | Distinct food preferences [Minimum Data Set] | | |
| 45437-1 | Eats between meals all or most days [Minimum Data Set] | | |
| 45438-9 | Use of alcohol at least weekly [Minimum Data Set] | | |
| 45439-7 | None of the listed eating patterns [Minimum Data Set] | | |
| 45440-5 | In bedclothes much of day [Minimum Data Set] | | |
| 45441-3 | Wakens to toilet all or most nights [Minimum Data Set] | | |
| 45442-1 | Has irregular bowel movement pattern [Minimum Data Set] | | |
| 45443-9 | Showers for bathing [Minimum Data Set] | | |
| 45444-7 | Bathing in PM [Minimum Data Set] | | |
| 45445-4 | None of the listed additional ADL patterns [Minimum Data Set] | | |
| 45446-2 | Daily contact with relatives/close friends [Minimum Data Set] | | |
| 45447-0 | Usually attends church, temple, etc. [Minimum Data Set] | | |
| 45448-8 | Finds strength in faith [Minimum Data Set] | | |
| 45449-6 | Daily animal companion/presence [Minimum Data Set] | | |
| 45450-4 | Involved in group activities [Minimum Data Set] | | |
| 45451-2 | None of the listed involvement patterns [Minimum Data Set] | | |
| 45452-0 | Unknown customary routine - resident/family unable to provide information [Minimum Data Set] | | |
| 45453-8 | Date of last day of MDS observation period [Minimum Data Set] | | |
| 45454-6 | Original or corrected copy of form # [Minimum Data Set] | | |
| 45455-3 | Date of reentry to facility [Minimum Data Set] | | |
| 45456-1 | Medicaid per diem [Minimum Data Set] | | |
| 45457-9 | Medicare per diem [Minimum Data Set] | | |
| 45458-7 | Medicare ancillary part A [Minimum Data Set] | | |
| 45459-5 | Medicare ancillary part B [Minimum Data Set] | | |
| 45460-3 | CHAMPUS Per Diem [Minimum Data Set] | | |
| 45461-1 | VA Per Diem [Minimum Data Set] | | |
| 45462-9 | Self or family pays for full per diem [Minimum Data Set] | | |
| 45463-7 | Medicaid resident liability or Medicare copayment [Minimum Data Set] | | |
| 45464-5 | Private insurance per diem [Minimum Data Set] | | |
| 45465-2 | Other per diem [Minimum Data Set] | | |
| 45466-0 | Legal guardian [Minimum Data Set] | | |
| 45467-8 | Other legal oversight [Minimum Data Set] | | |
| 45468-6 | Health care durable power attorney [Minimum Data Set] | | |
| 45469-4 | Financial durable power attorney [Minimum Data Set] | | |
| 45470-2 | Family member responsible [Minimum Data Set] | | |
| 45471-0 | Patient responsible for self [Minimum Data Set] | | |
| 45472-8 | Responsibility - none of above [Minimum Data Set] | | |
| 45474-4 | Advance directive - do not resuscitate [Minimum Data Set] | | |
| 45475-1 | Advance directive - do not hospitalize [Minimum Data Set] | | |
| 45476-9 | Advance directive - organ donation [Minimum Data Set] | | |
| 45477-7 | Advance directive - autopsy request [Minimum Data Set] | | |
| 45478-5 | Advance directive - feeding restrictions [Minimum Data Set] | | |
| 45479-3 | Advance directive - medication restrictions [Minimum Data Set] | | |
| 45480-1 | Advance directive - other treatment restrictions [Minimum Data Set] | | |
| 45481-9 | Advance directive - none [Minimum Data Set] | | |
| 45482-7 | Comatose [CMS Assessment] | | |
| 45483-5 | Short-term memory OK [Minimum Data Set] | | |
| 45484-3 | Long-term memory OK [Minimum Data Set] | | |
| 45485-0 | Can recall current season [Minimum Data Set] | | |
| 45486-8 | Can recall location of own room [Minimum Data Set] | | |
| 45487-6 | Can recall staff names/faces [Minimum Data Set] | | |
| 45488-4 | Can recall that he or she is in nursing home [Minimum Data Set] | | |
| 45489-2 | Memory/recall - none of above are recalled [Minimum Data Set] | | |
| 45490-0 | Cognitive skills for daily decision making [Minimum Data Set] | | |
| 45491-8 | Easily distracted [Minimum Data Set] | | |
| 45492-6 | Periods of altered perception or awareness of surroundings [Minimum Data Set] | | |
| 45493-4 | Episodes of disorganized speech [Minimum Data Set] | | |
| 45494-2 | Periods of restlessness [Minimum Data Set] | | |
| 45495-9 | Periods of lethargy [Minimum Data Set] | | |
| 45496-7 | Mental function varies over the course of the day [Minimum Data Set] | | |
| 45497-5 | Change in cognitive status [Minimum Data Set] | | |
| 45498-3 | Hearing [Minimum Data Set] | | |
| 45499-1 | Hearing aid present and used [Minimum Data Set] | | |
| 45500-6 | Hearing aid present and not used regularly [Minimum Data Set] | | |
| 45501-4 | Other receptive communication techniques used [Minimum Data Set] | | |
| 45502-2 | No communication device [Minimum Data Set] | | |
| 45503-0 | Uses speech [Minimum Data Set] | | |
| 45504-8 | Uses written messages to express or clarify needs [Minimum Data Set] | | |
| 45505-5 | Uses American sign language or Braille [Minimum Data Set] | | |
| 45506-3 | Uses signs/gestures/sounds [Minimum Data Set] | | |
| 45507-1 | Uses communication board [Minimum Data Set] | | |
| 45508-9 | Uses other modes of expression [Minimum Data Set] | | |
| 45509-7 | Modes of expression - none of above [Minimum Data Set] | | |
| 45510-5 | Making self understood [Minimum Data Set] | | |
| 45511-3 | Speech clarity [Minimum Data Set] | | |
| 45512-1 | Side vision problems [Minimum Data Set] | | |
| 45513-9 | Sees halos or rings around lights, flashes of light, or curtains over eyes [Minimum Data Set] | | |
| 45514-7 | No visual limitations [Minimum Data Set] | | |
| 45515-4 | Visual appliances [Minimum Data Set] | | |
| 45516-2 | Resident made negative statements [Minimum Data Set] | | |
| 45517-0 | Repetitive questions [Minimum Data Set] | | |
| 45518-8 | Repetitive verbalizations [Minimum Data Set] | | |
| 45519-6 | Persistent anger with self or others [Minimum Data Set] | | |
| 45520-4 | Self deprecation [Minimum Data Set] | | |
| 45521-2 | Expression of what appear to be unrealistic fears [Minimum Data Set] | | |
| 45522-0 | Recurrent statements that something terrible is about to happen [Minimum Data Set] | | |
| 45523-8 | Balance while sitting - position, trunk control [Minimum Data Set] | | |
| 45524-6 | Range of motion Neck [Minimum Data Set] | | |
| 45525-3 | Voluntary movement Neck [Minimum Data Set] | | |
| 45526-1 | Range of motion Upper extremity [Minimum Data Set] | | |
| 45527-9 | Voluntary movement Upper extremity [Minimum Data Set] | | |
| 45528-7 | Range of motion Hand [Minimum Data Set] | | |
| 45529-5 | Voluntary movement Hand [Minimum Data Set] | | |
| 45530-3 | Range of motion Lower extremity [Minimum Data Set] | | |
| 45531-1 | Voluntary movement Lower extremity [Minimum Data Set] | | |
| 45532-9 | Range of motion Foot [Minimum Data Set] | | |
| 45533-7 | Voluntary movement Foot [Minimum Data Set] | | |
| 45534-5 | Other limitation or loss - range of motion [Minimum Data Set] | | |
| 45535-2 | Other limitation or loss - voluntary movement [Minimum Data Set] | | |
| 45536-0 | Uses cane, walker or crutch [Minimum Data Set] | | |
| 45537-8 | Wheeled self [Minimum Data Set] | | |
| 45538-6 | Other person wheeled [Minimum Data Set] | | |
| 45539-4 | Wheelchair primary mode of locomotion [Minimum Data Set] | | |
| 45540-2 | No modes of locomotion [Minimum Data Set] | | |
| 45541-0 | Bedfast all or most of the time [Minimum Data Set] | | |
| 45542-8 | Bed rails used for bed mobility or transfer [Minimum Data Set] | | |
| 45543-6 | Lifted manually [Minimum Data Set] | | |
| 45544-4 | Lifted mechanically [Minimum Data Set] | | |
| 45545-1 | Transfer aid [Minimum Data Set] | | |
| 45546-9 | No mode of transfer [Minimum Data Set] | | |
| 45547-7 | Repetitive health complaints [Minimum Data Set] | | |
| 45548-5 | Repetitive anxious complaints or concerns [Minimum Data Set] | | |
| 45549-3 | Unpleasant mood in morning [Minimum Data Set] | | |
| 45550-1 | Insomnia/change in sleeping pattern [Minimum Data Set] | | |
| 45551-9 | Sad, pained, or worried facial expressions [Minimum Data Set] | | |
| 45552-7 | Crying or tearfulness [Minimum Data Set] | | |
| 45553-5 | Repetitive physical movements [Minimum Data Set] | | |
| 45554-3 | Withdrawal from activities of interest [Minimum Data Set] | | |
| 45555-0 | Reduced social interaction [Minimum Data Set] | | |
| 45556-8 | Mood persistence [Minimum Data Set] | | |
| 45557-6 | Change in mood [Minimum Data Set] | | |
| 45558-4 | Frequency of wandering [Minimum Data Set] | | |
| 45559-2 | Alterability of wandering [Minimum Data Set] | | |
| 45560-0 | Frequency of verbally abusive behavioral symptoms [Minimum Data Set] | | |
| 45561-8 | Alterability of verbally abusive behavioral symptoms [Minimum Data Set] | | |
| 45562-6 | Frequency of physically abusive behavioral symptoms [Minimum Data Set] | | |
| 45563-4 | Alterability of physically abusive behavioral symptoms [Minimum Data Set] | | |
| 45564-2 | Frequency of socially inappropriate or disruptive behavioral symptoms [Minimum Data Set] | | |
| 45565-9 | Alterability of socially inappropriate or disruptive behavioral symptoms [Minimum Data Set] | | |
| 45566-7 | Frequency of resists care [Minimum Data Set] | | |
| 45567-5 | Alterability of resists care [Minimum Data Set] | | |
| 45568-3 | Change in behavioral symptoms [Minimum Data Set] | | |
| 45569-1 | At ease interacting with others [Minimum Data Set] | | |
| 45570-9 | At ease doing planned or structured activities [Minimum Data Set] | | |
| 45571-7 | At ease doing self-initiated activities [Minimum Data Set] | | |
| 45572-5 | Establishes own goals [Minimum Data Set] | | |
| 45573-3 | Pursues involvement in life of facility [Minimum Data Set] | | |
| 45574-1 | Accepts invitations to most group activities [Minimum Data Set] | | |
| 45575-8 | Sense of initiative - none of above [Minimum Data Set] | | |
| 45576-6 | Covert/open conflict with or repeated criticism of staff [Minimum Data Set] | | |
| 45577-4 | Unhappy with roommate [Minimum Data Set] | | |
| 45578-2 | Unhappy with residents other than roommate [Minimum Data Set] | | |
| 45579-0 | Openly expresses conflict/anger with family/friends [Minimum Data Set] | | |
| 45580-8 | Absence of contact with family/friends [Minimum Data Set] | | |
| 45581-6 | Recent loss of close family member/friend [Minimum Data Set] | | |
| 45582-4 | Does not adjust easily to change in routines [Minimum Data Set] | | |
| 45583-2 | No unsettled relationships [Minimum Data Set] | | |
| 45584-0 | Strong identification with past roles and life status [Minimum Data Set] | | |
| 45585-7 | Expresses sadness/anger/empty feeling over lost roles/status [Minimum Data Set] | | |
| 45586-5 | Resident perceives that daily routine (customary routine, activities) is very different from prior pattern in the community [Minimum Data Set] | | |
| 45587-3 | Past roles - none of above [Minimum Data Set] | | |
| 45588-1 | Bed mobility - self-performance during assessment period [CMS Assessment] | | |
| 45589-9 | Bed mobility - support provided during assessment period [CMS Assessment] | | |
| 45590-7 | Transfer - self-performance during assessment period [CMS Assessment] | | |
| 45591-5 | Transfer - support provided during assessment period [CMS Assessment] | | |
| 45592-3 | Walk in room - self-performance during assessment period [CMS Assessment] | | |
| 45593-1 | Walk in room - support provided during assessment period [CMS Assessment] | | |
| 45594-9 | Walk in corridor - self-performance during assessment period [CMS Assessment] | | |
| 45595-6 | Walk in corridor - support provided during assessment period [CMS Assessment] | | |
| 45596-4 | Locomotion on unit - self-performance during assessment period [CMS Assessment] | | |
| 45597-2 | Locomotion on unit - support provided during assessment period [CMS Assessment] | | |
| 45598-0 | Locomotion off unit - self-performance during assessment period [CMS Assessment] | | |
| 45599-8 | Locomotion off unit - support provided during assessment period [CMS Assessment] | | |
| 45600-4 | Dressing - self-performance during assessment period [CMS Assessment] | | |
| 45601-2 | Dressing - support provided during assessment period [CMS Assessment] | | |
| 45602-0 | Eating - self-performance during assessment period [CMS Assessment] | | |
| 45603-8 | Eating - support provided during assessment period [CMS Assessment] | | |
| 45604-6 | Toilet use - self-performance during assessment period [CMS Assessment] | | |
| 1-8 | | Acyclovir [Susceptibility] | |
| 10-9 | | Amdinocillin [Susceptibility] by Serum bactericidal titer | |
| 100-8 | | Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC) | |
| 1000-9 | | DBG Ab [Presence] in Serum or Plasma from Blood product unit | |
| 10000-8 | | R wave duration in lead AVR | |
| 100000-9 | | Health informatics pioneer and the father of LOINC | |
| 100001-7 | | Health informatics pioneer and cofounder of LOINC | |
| 10001-6 | | R wave duration in lead I | |
| 100018-1 | | Hospice care Note | |
| 100019-9 | | ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 10002-4 | | R wave duration in lead II | |
| 100020-7 | | GNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100021-5 | | GNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100022-3 | | IDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100023-1 | | IDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100024-9 | | SETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100025-6 | | SRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100026-4 | | MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100027-2 | | SMAD4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100028-0 | | FBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100029-8 | | Cancer related multigene analysis in Plasma cell-free DNA by Molecular genetics method | |
| 10003-2 | | R wave duration in lead III | |
| 100034-8 | | Provider of automated external defibrillator use | |
| 100035-5 | | Exam finding location of Chest | |
| 100036-3 | | Exam finding location of Lung | |
| 100037-1 | | Patient contact disposition EMS unit | |
| 100038-9 | | Patient evaluation disposition EMS unit | |
| 100039-7 | | Crew disposition for patient care EMS unit | |
| 10004-0 | | R wave duration in lead V1 | |
| 100040-5 | | Patient transport disposition EMS unit | |
| 100041-3 | | Aminoglycoside [Susceptibility] | |
| 100042-1 | | Atovaquone [Susceptibility] | |
| 100043-9 | | Azithromycin+Ethambutol [Susceptibility] | |
| 100044-7 | | Cefcapene [Susceptibility] | |
| 100045-4 | | Cefozopran [Susceptibility] | |
| 100046-2 | | Cefquinome [Susceptibility] | |
| 100047-0 | | Cefteram [Susceptibility] | |
| 100048-8 | | Clarithromycin+Ethambutol [Susceptibility] | |
| 100049-6 | | Eravacycline [Susceptibility] | |
| 10005-7 | | R wave duration in lead V2 | |
| 100050-4 | | Erythromycin+Ethambutol [Susceptibility] | |
| 100051-2 | | Ethambutol+rifAMPin [Susceptibility] | |
| 100052-0 | | Flomoxef [Susceptibility] | |
| 100053-8 | | Fluoroquinolone [Susceptibility] | |
| 100054-6 | | Gamithromycin [Susceptibility] | |
| 100055-3 | | Optochin [Susceptibility] | |
| 100056-1 | | Panipenem [Susceptibility] | |
| 100057-9 | | Prothionamide [Susceptibility] | |
| 100058-7 | | Prulifloxacin [Susceptibility] | |
| 100059-5 | | Rifapentine [Susceptibility] | |
| 10006-5 | | R wave duration in lead V3 | |
| 100060-3 | | Tildipirosin [Susceptibility] | |
| 100061-1 | | Tosufloxacin [Susceptibility] | |
| 100062-9 | | Standard Dermatology Outcome Measures panel | |
| 100063-7 | | Primary skin concern | |
| 100064-5 | | Itch severity Reporting Period - Reported | |
| 100065-2 | | Satisfied with treatment | |
| 100066-0 | | Specular microscopy panel | |
| 100067-8 | | Eye Image magnification | |
| 100068-6 | | Right eye Fixation point [Angle] | |
| 100069-4 | | Left eye Fixation point [Angle] | |
| 10007-3 | | R wave duration in lead V4 | |
| 100070-2 | | Right cornea Cell density | |
| 100071-0 | | Left cornea Cell density | |
| 100072-8 | | Right cornea Coefficient of variation | |
| 100073-6 | | Left cornea Coefficient of variation | |
| 100074-4 | | Right cornea Hexagonality | |
| 100075-1 | | Left cornea Hexagonality | |
| 100076-9 | | Right cornea Endothelial cells counted | |
| 100077-7 | | Left cornea Endothelial cells counted | |
| 100078-5 | | Right cornea Endothelial cell area.min | |
| 100079-3 | | Left cornea Endothelial cell area.min | |
| 10008-1 | | R wave duration in lead V5 | |
| 100080-1 | | Right cornea Endothelial cell area.max | |
| 100081-9 | | Left cornea Endothelial cell area.max | |
| 100082-7 | | Right cornea Endothelial cell area.mean | |
| 100083-5 | | Left cornea Endothelial cell area.mean | |
| 100084-3 | | Right cornea Cell area.standard deviation | |
| 100085-0 | | Left cornea Cell area.standard deviation | |
| 100086-8 | | Right cornea Type of Analysis method by Specular microscopy | |
| 100087-6 | | Toxocara canis 24-35kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100088-4 | | Taenia solium larva Ab bands panel - Serum by Immunoblot | |
| 100089-2 | | Taenia solium larva 6-8kD Ab [Presence] in Serum by Immunoblot | |
| 10009-9 | | R wave duration in lead V6 | |
| 100090-0 | | Taenia solium larva 45kD Ab [Presence] in Serum by Immunoblot | |
| 100091-8 | | Trypanosoma cruzi Ab [Units/volume] in Serum by Immunoassay | |
| 100092-6 | | Trypanosoma cruzi Ab bands panel - Serum by Immunoblot | |
| 100093-4 | | Trypanosoma cruzi 15-16kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100094-2 | | Trypanosoma cruzi 21-22kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100095-9 | | Trypanosoma cruzi 27-28kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100096-7 | | Trypanosoma cruzi 42kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100097-5 | | Trypanosoma cruzi 45-47kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100098-3 | | Trypanosoma cruzi 120-200kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100099-1 | | Trypanosoma cruzi 160kD IgG Ab [Presence] in Serum by Immunoblot | |
| 1001-7 | | DBG Ab [Presence] in Serum or Plasma from Donor | |
| 10010-7 | | R' wave amplitude in lead AVF | |
| 100100-7 | | Fasciola sp IgG Ab [Presence] in Serum by Immunoassay | |
| 100101-5 | | Fasciola sp 8-9kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100102-3 | | Fasciola sp 27-28kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100103-1 | | Fasciola sp 60kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100104-9 | | Fasciola sp 42kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100105-6 | | Filaria IgG and IgM panel - Serum | |
| 100106-4 | | Filaria IgG Ab [Presence] in Serum by Immunoassay | |
| 100107-2 | | Leishmania sp IgG Ab [Presence] in Serum by Immunoassay | |
| 100108-0 | | Leishmania sp IgG Ab [Units/volume] in Serum by Immunoassay | |
| 100109-8 | | Leishmania sp Ab bands panel - Serum by Immunoblot | |
| 10011-5 | | R' wave amplitude in lead AVL | |
| 100110-6 | | Leishmania sp 14kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100111-4 | | Leishmania sp 16kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100112-2 | | Fasciola sp Ab bands panel - Serum by Immunoblot | |
| 100113-0 | | Helicobacter pylori Ab panel - Serum | |
| 100114-8 | | Toxoplasma gondii 30kD Ab [Presence] in Serum by Immunoblot | |
| 100115-5 | | Toxoplasma gondii 31kD Ab [Presence] in Serum by Immunoblot | |
| 100116-3 | | Toxoplasma gondii 33kD Ab [Presence] in Serum by Immunoblot | |
| 100117-1 | | Toxoplasma gondii 40kD Ab [Presence] in Serum by Immunoblot | |
| 100118-9 | | Toxoplasma gondii 41kD Ab [Presence] in Serum by Immunoblot | |
| 100119-7 | | Toxoplasma gondii 45kD Ab [Presence] in Serum by Immunoblot | |
| 10012-3 | | R' wave amplitude in lead AVR | |
| 100120-5 | | Chlamydia trachomatis Ab panel - Serum | |
| 100121-3 | | Chlamydia trachomatis IgA Ab [Presence] in Serum by Immunoassay | |
| 100122-1 | | Chlamydophila pneumoniae Ab panel - Serum | |
| 100123-9 | | Chlamydophila pneumoniae IgA Ab [Presence] in Serum by Immunoassay | |
| 100124-7 | | Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum by Immunoassay | |
| 100125-4 | | Chlamydophila psittaci Ab panel - Serum | |
| 100126-2 | | Bordetella pertussis Ab.IgG panel - Serum | |
| 100127-0 | | Campylobacter sp Ab panel - Serum | |
| 100128-8 | | Cryptococcus sp Ag panel - Serum | |
| 100129-6 | | Schistosoma sp Ab [Titer] in Serum by Hemagglutination | |
| 10013-1 | | R' wave amplitude in lead I | |
| 100130-4 | | Schistosoma mansoni Ab [Presence] in Serum by Immunoblot | |
| 100131-2 | | Schistosoma sp 8kD Ab [Presence] in Serum by Immunoblot | |
| 100132-0 | | Schistosoma sp 9kD Ab [Presence] in Serum by Immunoblot | |
| 100133-8 | | Schistosoma sp 10kD Ab [Presence] in Serum by Immunoblot | |
| 100134-6 | | Schistosoma sp 11kD Ab [Presence] in Serum by Immunoblot | |
| 100135-3 | | Schistosoma sp 12-13kD Ab [Presence] in Serum by Immunoblot | |
| 100136-1 | | Schistosoma sp 14-15kD Ab [Presence] in Serum by Immunoblot | |
| 100137-9 | | Schistosoma sp 15-16kD Ab [Presence] in Serum by Immunoblot | |
| 100138-7 | | Schistosoma sp 18-19kD Ab [Presence] in Serum by Immunoblot | |
| 100139-5 | | Schistosoma sp 22-24kD Ab [Presence] in Serum by Immunoblot | |
| 10014-9 | | R' wave amplitude in lead II | |
| 100140-3 | | Schistosoma sp 30-34kD Ab [Presence] in Serum by Immunoblot | |
| 100141-1 | | Schistosoma sp 65kD Ab [Presence] in Serum by Immunoblot | |
| 100142-9 | | Schistosoma sp 70kD Ab [Presence] in Serum by Immunoblot | |
| 100143-7 | | Schistosoma sp 80kD Ab [Presence] in Serum by Immunoblot | |
| 100144-5 | | Schistosoma sp 95kD Ab [Presence] in Serum by Immunoblot | |
| 100145-2 | | Schistosoma sp 110kD Ab [Presence] in Serum by Immunoblot | |
| 100146-0 | | Schistosoma sp 120kD Ab [Presence] in Serum by Immunoblot | |
| 100147-8 | | Toxoplasma gondii Ab bands panel - Serum by Immunoblot | |
| 100148-6 | | Schistosoma sp Ab bands panel - Serum by Immunoblot | |
| 100149-4 | | 6-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel - Urine and Serum or Plasma | |
| 10015-6 | | R' wave amplitude in lead III | |
| 100150-2 | | 6(R+S)-oxo-propylpiperidine-2-carboxylate [Moles/volume] in Plasma | |
| 100151-0 | | 6-oxo-piperidine-2-carboxylate [Moles/volume] in Plasma | |
| 100152-8 | | 6-oxo-piperidine-2-carboxylate/Creatinine [Molar ratio] in Urine | |
| 100153-6 | | 6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine [Molar ratio] in Urine | |
| 100154-4 | | Specimen collection supervision level | |
| 100155-1 | | Left cornea Type of Analysis method by Specular microscopy | |
| 100156-9 | | SARS-CoV-2 (COVID-19) variant [Type] in Specimen by NAA with probe detection | |
| 100157-7 | | SARS-CoV-2 (COVID-19) lineage [Type] in Specimen by Sequencing | |
| 100158-5 | | Microalbumin [Mass/volume] in Urine collected for unspecified duration | |
| 10016-4 | | R' wave amplitude in lead V1 | |
| 100160-1 | | Knee replacement | |
| 100161-9 | | Charnley Functional Classification | |
| 100162-7 | | Knee alignment W standing X-ray measured | |
| 100163-5 | | Knee medial AndOr lateral instability W full extension | |
| 100164-3 | | Knee AP instability W 90 degree flexion | |
| 100165-0 | | Knee range of motion | |
| 100166-8 | | Flexion contracture range of Knee | |
| 100167-6 | | Extensor lag range of Knee | |
| 10017-2 | | R' wave amplitude in lead V2 | |
| 10018-0 | | R' wave amplitude in lead V3 | |
| 10019-8 | | R' wave amplitude in lead V4 | |
| 1002-5 | | DBG Ab [Presence] in Serum or Plasma | |
| 10020-6 | | R' wave amplitude in lead V5 | |
| 10021-4 | | R' wave amplitude in lead V6 | |
| 100213-8 | | Prostate cancer multigene analysis in Blood or Tissue by Molecular genetics method | |
| 100214-6 | | Dental model prior authorization Document | |
| 100215-3 | | Episode of care medical records Document Transplant surgery | |
| 100216-1 | | Surgical synoptic report | |
| 100217-9 | | Surgical oncology synoptic report | |
| 100218-7 | | Surgical oncology of colon synoptic report | |
| 100219-5 | | Surgical oncology of melanoma synoptic report | |
| 10022-2 | | R' wave duration in lead AVF | |
| 100220-3 | | Surgical oncology of breast synoptic report | |
| 100221-1 | | Surgical oncology of thyroid synoptic report | |
| 100222-9 | | Surgical oncology of pancreas synoptic report | |
| 100223-7 | | Physical findings of Retina Narrative | |
| 100224-5 | | Cardiac left ventricular segmental wall motion by echo panel | |
| 100225-2 | | Bone density quantitative ultrasound study | |
| 100226-0 | | Small bowel capsule endoscopy study Document | |
| 100227-8 | | Colon capsule endoscopy study Document | |
| 100228-6 | | Upper gastrointestinal capsule endoscopy study Document | |
| 100229-4 | | Endoscopic ultrasound study Document | |
| 10023-0 | | R' wave duration in lead AVL | |
| 100230-2 | | Routine prenatal assessment panel | |
| 100231-0 | | Endobronchial ultrasound study | |
| 10024-8 | | R' wave duration in lead AVR | |
| 10025-5 | | R' wave duration in lead I | |
| 100256-7 | | Fallen in last 6 months | |
| 100257-5 | | Feel unsteady when standing or walking | |
| 100258-3 | | History of fall related injury | |
| 10026-3 | | R' wave duration in lead II | |
| 10027-1 | | R' wave duration in lead III | |
| 10028-9 | | R' wave duration in lead V1 | |
| 100281-5 | | D Ab [Units/volume] in Serum or Plasma | |
| 100282-3 | | Vaccine exemption certificate | |
| 10029-7 | | R' wave duration in lead V2 | |
| 100298-9 | | Repetition count | |
| 1003-3 | | Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma | |
| 10030-5 | | R' wave duration in lead V3 | |
| 100300-3 | | End time Unspecified body region | |
| 100301-1 | | Start time Unspecified body region | |
| 100302-9 | | Time period start and end panel Unspecified body region | |
| 100303-7 | | Condition certainty of presence | |
| 100304-5 | | Flights climbed [#] Reporting Period | |
| 100305-2 | | IDH1 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method | |
| 100306-0 | | IDH2 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method | |
| 10031-3 | | R' wave duration in lead V4 | |
| 10032-1 | | R' wave duration in lead V5 | |
| 10033-9 | | R' wave duration in lead V6 | |
| 10034-7 | | S wave amplitude in lead AVF | |
| 100341-7 | | Rubella virus IgG Ab index [Units/volume] in Serum and CSF | |
| 100342-5 | | Volatile Organic Compounds associated with SARS-CoV-2 infection [Presence] in Exhaled gas by Gas chromatography-mass spectrometry | |
| 100343-3 | | Influenza virus B RNA [Presence] in Saliva (oral fluid) by NAA with probe detection | |
| 100344-1 | | Influenza virus A RNA [Presence] in Saliva (oral fluid) by NAA with probe detection | |
| 100345-8 | | Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection | |
| 100346-6 | | Clotting time.extrinsic coagulation system activated.platelets inhibited of Blood by Rotational TEG | |
| 100347-4 | | Clot formation.extrinsic coagulation system activated.platelets inhibited [Time] in Blood by Rotational TEG | |
| 100348-2 | | Model for end-stage liver disease sodium score | |
| 100349-0 | | US.doppler Penis vessels W vasodilator IV | |
| 10035-4 | | S wave amplitude in lead AVL | |
| 100350-8 | | Sesamum indicum 1 IgE Ab [Units/volume] in Serum | |
| 100351-6 | | Pioglitazone [Presence] in Serum or Plasma | |
| 100352-4 | | Rosiglitazone [Presence] in Serum or Plasma | |
| 100356-5 | | Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA [Identifier] in Specimen by NAA with probe detection | |
| 100357-3 | | Naloxone [Presence] in Cord tissue by Screen method | |
| 100358-1 | | Phentermine [Presence] in Cord tissue by Screen method | |
| 100359-9 | | Gliadin 33 mer peptide [Mass/volume] in Stool by Immunoassay | |
| 10036-2 | | S wave amplitude in lead AVR | |
| 100368-0 | | Amino Acids Urea Cycle Panel - Serum or Plasma by LC/MS/MS | |
| 100369-8 | | NM Thyroid gland Views W Tl-201 IV | |
| 10037-0 | | S wave amplitude in lead I | |
| 100370-6 | | Orthopoxvirus DNA [Identifier] in Specimen by NAA with probe detection | |
| 100371-4 | | Titin Ab [Units/volume] in Serum by Immunoassay | |
| 100372-2 | | Abiraterone [Mass/volume] in Serum or Plasma | |
| 100373-0 | | Eucheuma IgG Ab [Units/volume] in Serum | |
| 100374-8 | | Aloe vera IgG Ab [Units/volume] in Serum | |
| 100375-5 | | Anise IgG Ab [Units/volume] in Serum | |
| 100376-3 | | Bambusa vulgaris IgG Ab [Units/volume] in Serum | |
| 100377-1 | | Goat cheese IgG Ab [Units/volume] in Serum | |
| 100378-9 | | Sheep cheese IgG Ab [Units/volume] in Serum | |
| 100379-7 | | Leeks IgG Ab [Units/volume] in Serum | |
| 10038-8 | | S wave amplitude in lead II | |
| 100380-5 | | Red cabbage IgG Ab [Units/volume] in Serum | |
| 100381-3 | | Mentha balsamea Wild IgG Ab [Units/volume] in Serum | |
| 100382-1 | | FDA package insert REMS addressed risk | |
| 100383-9 | | Monkeypox virus DNA [Presence] in Specimen by NAA with probe detection | |
| 100384-7 | | Rapeseed IgG Ab [Units/volume] in Serum | |
| 100385-4 | | Corn salad IgG Ab [Units/volume] in Serum | |
| 100386-2 | | Rosemary IgG Ab [Units/volume] in Serum | |
| 100387-0 | | Poppy Seed IgG Ab [Units/volume] in Serum | |
| 100388-8 | | Cocoa IgG Ab [Units/volume] in Serum | |
| 100389-6 | | Pistachio IgG Ab [Units/volume] in Serum | |
| 10039-6 | | S wave amplitude in lead III | |
| 100390-4 | | Sunflower Seed IgG Ab [Units/volume] in Serum | |
| 100391-2 | | Dates IgG Ab [Units/volume] in Serum | |
| 100392-0 | | Duck meat IgG Ab [Units/volume] in Serum | |
| 100393-8 | | Allergen Mushroom mix 2 (Xerocomus, Boletus) IgG Ab [Units/volume] in Serum | |
| 100394-6 | | Astacoidea IgG Ab [Units/volume] in Serum | |
| 100395-3 | | Carob IgG Ab [Units/volume] in Serum | |
| 100396-1 | | Brassica napus IgG Ab [Units/volume] in Serum | |
| 100397-9 | | Goat Meat IgG Ab [Units/volume] in Serum | |
| 100398-7 | | Goose meat IgG Ab [Units/volume] in Serum | |
| 100399-5 | | Ostrich meat IgG Ab [Units/volume] in Serum | |
| 1004-1 | | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells | |
| 10040-4 | | S wave amplitude in lead V1 | |
| 100400-1 | | Quail meat IgG Ab [Units/volume] in Serum | |
| 100401-9 | | Rabbit meat IgG Ab [Units/volume] in Serum | |
| 100402-7 | | Venison meat IgG Ab [Units/volume] in Serum | |
| 100403-5 | | Guineafowl IgG Ab [Units/volume] in Serum | |
| 100404-3 | | Horse meat IgG Ab [Units/volume] in Serum | |
| 100405-0 | | Kefir IgG Ab [Units/volume] in Serum | |
| 100406-8 | | Butter IgG Ab [Units/volume] in Serum | |
| 100407-6 | | Camembert cheese IgG Ab [Units/volume] in Serum | |
| 100408-4 | | Emmental cheese IgG Ab [Units/volume] in Serum | |
| 100409-2 | | Processed cheese IgG Ab [Units/volume] in Serum | |
| 10041-2 | | S wave amplitude in lead V2 | |
| 100410-0 | | Curd cheese IgG Ab [Units/volume] in Serum | |
| 100411-8 | | Sugar Beet IgG Ab [Units/volume] in Serum | |
| 100412-6 | | Chinese cabbage IgG Ab [Units/volume] in Serum | |
| 100413-4 | | Fennel Fresh IgG Ab [Units/volume] in Serum | |
| 100414-2 | | Gourd IgG Ab [Units/volume] in Serum | |
| 100415-9 | | Kale IgG Ab [Units/volume] in Serum | |
| 100416-7 | | Savoy cabbage IgG Ab [Units/volume] in Serum | |
| 100417-5 | | Vitis sp leaf IgG Ab [Units/volume] in Serum | |
| 100418-3 | | Liquorice IgG Ab [Units/volume] in Serum | |
| 100419-1 | | Snow pea IgG Ab [Units/volume] in Serum | |
| 10042-0 | | S wave amplitude in lead V3 | |
| 100420-9 | | Fava bean IgG Ab [Units/volume] in Serum | |
| 100421-7 | | Chick Pea IgG Ab [Units/volume] in Serum | |
| 100422-5 | | Chicory IgG Ab [Units/volume] in Serum | |
| 100423-3 | | Allergy Mushroom Mix 1 (Button + oyster + Shiitaki + chanterelle mushroom) IgG Ab [Units/volume] in Serum | |
| 100424-1 | | 8(9)-Cholestenol [Mass/volume] in Serum or Plasma | |
| 100425-8 | | DiHydro T-Mas [Mass/volume] in Serum or Plasma | |
| 100426-6 | | Squalene [Mass/volume] in Serum or Plasma | |
| 100427-4 | | Stigmasterol [Mass/volume] in Serum or Plasma | |
| 100428-2 | | Carnitine free and total and acylcarnitine panel - Urine | |
| 100429-0 | | LRBA deficiency panel - Blood | |
| 10043-8 | | S wave amplitude in lead V4 | |
| 100430-8 | | Cells.LRBA+/100 Cells.CD3+CD14-CD45+ in Blood by Flow cytometry (FC) | |
| 100431-6 | | Cells.CD3+CD14-CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) | |
| 100432-4 | | Cells.LRBA+/100 Cells.CD3-CD14-CD19+CD45+ in Blood by Flow cytometry (FC) | |
| 100433-2 | | Cells.CD3-CD14-CD19+CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) | |
| 100434-0 | | Orthopoxvirus.non-variola DNA [Presence] in Specimen by NAA with probe detection | |
| 100435-7 | | Glial fibrillary acidic protein [Mass/volume] in Serum by Immunoassay | |
| 100436-5 | | Ubiquitin carboxyl-terminal hydrolase-L1 [Mass/volume] in Serum by Immunoassay | |
| 100437-3 | | Norsufentanil [Mass/volume] in Urine by Confirmatory method | |
| 100438-1 | | Adolescent medicine Outpatient Progress note | |
| 100439-9 | | Allergy and Immunology Outpatient Progress note | |
| 10044-6 | | S wave amplitude in lead V5 | |
| 100440-7 | | Allergy Outpatient Progress note | |
| 100441-5 | | Attending Outpatient Progress note | |
| 100442-3 | | Audiology Outpatient Progress note | |
| 100443-1 | | Bariatric surgery Outpatient Progress note | |
| 100444-9 | | Blood banking and transfusion medicine Outpatient Progress note | |
| 100445-6 | | Bone Marrow Transplant Outpatient Progress note | |
| 100446-4 | | Breastfeeding Outpatient Progress note | |
| 100447-2 | | Burn management Outpatient Progress note | |
| 100448-0 | | Cardiac surgery Outpatient Progress note | |
| 100449-8 | | Cardiopulmonary Outpatient Progress note | |
| 10045-3 | | S wave amplitude in lead V6 | |
| 100450-6 | | Child and adolescent psychiatry Outpatient Progress note | |
| 100451-4 | | Chiropractic medicine Outpatient Progress note | |
| 100452-2 | | Clinical cardiac electrophysiology Outpatient Progress note | |
| 100453-0 | | Clinical genetics Outpatient Progress note | |
| 100454-8 | | Clinical neurophysiology Outpatient Progress note | |
| 100455-5 | | Clinical pathology Outpatient Progress note | |
| 100456-3 | | Colon and rectal surgery Outpatient Progress note | |
| 100457-1 | | Consultant Outpatient Progress note | |
| 100458-9 | | Outpatient COVID-19 Intubation Progress note | |
| 100459-7 | | Outpatient COVID-19 Progress note | |
| 10046-1 | | S wave duration in lead AVF | |
| 100460-5 | | Dermatology Outpatient Progress note | |
| 100461-3 | | Developmental-behavioral pediatrics Outpatient Progress note | |
| 100462-1 | | Dialysis and Therapeutic apheresis Outpatient Progress note | |
| 100463-9 | | Eating disorders Outpatient Progress note | |
| 100464-7 | | Endocrinology Outpatient Progress note | |
| 100465-4 | | Family medicine Outpatient Progress note | |
| 100466-2 | | Gastroenterology Outpatient Progress note | |
| 100467-0 | | Geriatric medicine Outpatient Progress note | |
| 100468-8 | | Gynecologic oncology Outpatient Progress note | |
| 100469-6 | | Gynecology Outpatient Progress note | |
| 10047-9 | | S wave duration in lead AVL | |
| 100470-4 | | Healthcare navigator Outpatient Progress note | |
| 100471-2 | | Heart failure Outpatient Progress note | |
| 100472-0 | | Heart failure+Transplant cardiology Outpatient Progress note | |
| 100473-8 | | Hematology Outpatient Progress note | |
| 100474-6 | | Hematology+Medical oncology Outpatient Progress note | |
| 100475-3 | | Hepatology Outpatient Progress note | |
| 100476-1 | | Immunology Outpatient Progress note | |
| 100477-9 | | Infectious disease Outpatient Progress note | |
| 100478-7 | | Internal medicine Outpatient Progress note | |
| 100479-5 | | Interventional cardiology Outpatient Progress note | |
| 10048-7 | | S wave duration in lead AVR | |
| 100480-3 | | Interventional radiology Outpatient Progress note | |
| 100481-1 | | Outpatient Mechanical circulatory support Progress note | |
| 100482-9 | | Medical Aid in Dying Outpatient Progress note | |
| 100483-7 | | Mental health Outpatient Progress note | |
| 100484-5 | | Multi-specialty program Outpatient Progress note | |
| 100485-2 | | Neonatal perinatal medicine Outpatient Progress note | |
| 100486-0 | | Nephrology Outpatient Progress note | |
| 100487-8 | | Neurological surgery Outpatient Progress note | |
| 100488-6 | | Neurology Outpatient Progress note | |
| 100489-4 | | Neurology with special qualifications in child neurology Outpatient Progress note | |
| 10049-5 | | S wave duration in lead I | |
| 100490-2 | | Nurse practitioner Outpatient Progress note | |
| 100491-0 | | Nurse Outpatient Progress note | |
| 100492-8 | | Nutrition and dietetics Outpatient Progress note | |
| 100493-6 | | Obstetrics and Gynecology Outpatient Progress note | |
| 100494-4 | | Obstetrics Outpatient Progress note | |
| 100495-1 | | Occupational therapy Outpatient Progress note | |
| 100496-9 | | Oncology Outpatient Progress note | |
| 100497-7 | | Ophthalmology Outpatient Progress note | |
| 100498-5 | | Optometry Outpatient Progress note | |
| 100499-3 | | Oral and Maxillofacial Surgery Outpatient Progress note | |
| 1005-8 | | Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma | |
| 10050-3 | | S wave duration in lead II | |
| 100500-8 | | Orthopaedic surgery Outpatient Progress note | |
| 100501-6 | | Orthotics prosthetics Outpatient Progress note | |
| 100502-4 | | Otolaryngology Outpatient Progress note | |
| 100503-2 | | Pain medicine Outpatient Progress note | |
| 100504-0 | | Palliative care Outpatient Progress note | |
| 100505-7 | | Pediatric cardiology Outpatient Progress note | |
| 100506-5 | | Pediatric dermatology Outpatient Progress note | |
| 100507-3 | | Pediatric endocrinology Outpatient Progress note | |
| 100508-1 | | Pediatric gastroenterology Outpatient Progress note | |
| 100509-9 | | Pediatric hematology-oncology Outpatient Progress note | |
| 10051-1 | | S wave duration in lead III | |
| 100510-7 | | Pediatric infectious diseases Outpatient Progress note | |
| 100511-5 | | Pediatric otolaryngology Outpatient Progress note | |
| 100512-3 | | Pediatric pulmonology Outpatient Progress note | |
| 100513-1 | | Pediatric rheumatology Outpatient Progress note | |
| 100514-9 | | Pediatric surgery Outpatient Progress note | |
| 100515-6 | | Pediatric transplant hepatology Outpatient Progress note | |
| 100516-4 | | Pediatric urology Outpatient Progress note | |
| 100517-2 | | Pharmacogenomics Outpatient Progress note | |
| 100518-0 | | Physical medicine and rehab Outpatient Progress note | |
| 100519-8 | | Physical therapy Outpatient Progress note | |
| 10052-9 | | S wave duration in lead V1 | |
| 100520-6 | | Plastic surgery Outpatient Progress note | |
| 100521-4 | | Podiatry Outpatient Progress note | |
| 100522-2 | | Psychiatry Hospital Progress note | |
| 100523-0 | | Psychology Outpatient Progress note | |
| 100524-8 | | Pulmonary Outpatient Progress note | |
| 100525-5 | | Radiation oncology Outpatient Progress note | |
| 100526-3 | | Radiology Outpatient Progress note | |
| 100527-1 | | Recreational therapy Outpatient Progress note | |
| 100528-9 | | Reproductive endocrinology and infertility Outpatient Progress note | |
| 100529-7 | | Research Outpatient Progress note | |
| 10053-7 | | S wave duration in lead V2 | |
| 100530-5 | | Rheumatology Outpatient Progress note | |
| 100531-3 | | Sleep medicine Outpatient Progress note | |
| 100532-1 | | Social worker Outpatient Progress note | |
| 100533-9 | | Solid Organ Transplant Outpatient Progress note | |
| 100534-7 | | Speech-language pathology Outpatient Progress note | |
| 100535-4 | | Spinal surgery Outpatient Progress note | |
| 100536-2 | | Sports medicine Outpatient Progress note | |
| 100537-0 | | Surgery of the hand Outpatient Progress note | |
| 100538-8 | | Telehealth+Outpatient Progress note | |
| 100539-6 | | Thromboembolism Outpatient Progress note | |
| 10054-5 | | S wave duration in lead V3 | |
| 100540-4 | | Transplant surgery Outpatient Progress note | |
| 100541-2 | | Trauma Outpatient Progress note | |
| 100542-0 | | Urology Outpatient Progress note | |
| 100543-8 | | Vascular neurology Outpatient Progress note | |
| 100544-6 | | Vascular surgery Outpatient Progress note | |
| 100545-3 | | Wound care management Outpatient Progress note | |
| 100546-1 | | Wound, Ostomy, and Continence Care Outpatient Progress note | |
| 100547-9 | | Adolescent medicine Hospital Progress note | |
| 100548-7 | | Allergy and Immunology Hospital Progress note | |
| 100549-5 | | Allergy Hospital Progress note | |
| 10055-2 | | S wave duration in lead V4 | |
| 100550-3 | | Attending Hospital Progress note | |
| 100551-1 | | Audiology Hospital Progress note | |
| 100552-9 | | Bariatric surgery Hospital Progress note | |
| 100553-7 | | Blood banking and transfusion medicine Hospital Progress note | |
| 100554-5 | | Bone Marrow Transplant Hospital Progress note | |
| 100555-2 | | Breastfeeding Hospital Progress note | |
| 100556-0 | | Burn management Hospital Progress note | |
| 100557-8 | | Cardiac surgery Hospital Progress note | |
| 100558-6 | | Cardiopulmonary Hospital Progress note | |
| 100559-4 | | Child and adolescent psychiatry Hospital Progress note | |
| 10056-0 | | S wave duration in lead V5 | |
| 100560-2 | | Clinical cardiac electrophysiology Hospital Progress note | |
| 100561-0 | | Clinical genetics Hospital Progress note | |
| 100562-8 | | Clinical neurophysiology Hospital Progress note | |
| 100563-6 | | Clinical pathology Hospital Progress note | |
| 100564-4 | | Colon and rectal surgery Hospital Progress note | |
| 100565-1 | | Consultant Hospital Progress note | |
| 100566-9 | | Dentistry Hospital Progress note | |
| 100567-7 | | Dermatology Hospital Progress note | |
| 100568-5 | | Developmental-behavioral pediatrics Hospital Progress note | |
| 100569-3 | | Dialysis and Therapeutic apheresis Hospital Progress note | |
| 10057-8 | | S wave duration in lead V6 | |
| 100570-1 | | Eating disorders Hospital Progress note | |
| 100571-9 | | Endocrinology Hospital Progress note | |
| 100572-7 | | Family medicine Hospital Progress note | |
| 100573-5 | | Gastroenterology Hospital Progress note | |
| 100574-3 | | General medicine Hospital Progress note | |
| 100575-0 | | Geriatric medicine Hospital Progress note | |
| 100576-8 | | Gynecologic oncology Hospital Progress note | |
| 100577-6 | | Gynecology Hospital Progress note | |
| 100578-4 | | Healthcare navigator Hospital Progress note | |
| 100579-2 | | Heart failure Hospital Progress note | |
| 10058-6 | | S' wave amplitude in lead AVF | |
| 100580-0 | | Heart failure+Transplant cardiology Hospital Progress note | |
| 100581-8 | | Hematology Hospital Progress note | |
| 100582-6 | | Hematology+Medical oncology Hospital Progress note | |
| 100583-4 | | Hepatology Hospital Progress note | |
| 100584-2 | | Immunology Hospital Progress note | |
| 100585-9 | | Infectious disease Hospital Progress note | |
| 100586-7 | | Internal medicine Hospital Progress note | |
| 100587-5 | | Interventional cardiology Hospital Progress note | |
| 100588-3 | | Interventional radiology Hospital Progress note | |
| 100589-1 | | Hospital Mechanical circulatory support Progress note | |
| 10059-4 | | S' wave amplitude in lead AVL | |
| 100590-9 | | Medical Aid in Dying Hospital Progress note | |
| 100591-7 | | Mental health Hospital Progress note | |
| 100592-5 | | Multi-specialty program Hospital Progress note | |
| 100593-3 | | Neonatal perinatal medicine Hospital Progress note | |
| 100594-1 | | Nephrology Hospital Progress note | |
| 100595-8 | | Neurological surgery Hospital Progress note | |
| 100596-6 | | Neurology Hospital Progress note | |
| 100597-4 | | Neurology with special qualifications in child neurology Hospital Progress note | |
| 100598-2 | | Nurse practitioner Hospital Progress note | |
| 100599-0 | | Nurse Hospital Progress note | |
| 1006-6 | | Direct antiglobulin test.IgG specific reagent [Interpretation] on Red Blood Cells | |
| 10060-2 | | S' wave amplitude in lead AVR | |
| 100600-6 | | Nutrition and dietetics Hospital Progress note | |
| 100601-4 | | Obstetrics and Gynecology Hospital Progress note | |
| 100602-2 | | Obstetrics Hospital Progress note | |
| 100603-0 | | Occupational therapy Hospital Progress note | |
| 100604-8 | | Oncology Hospital Progress note | |
| 100605-5 | | Ophthalmology Hospital Progress note | |
| 100606-3 | | Oral and Maxillofacial Surgery Hospital Progress note | |
| 100607-1 | | Orthopaedic surgery Hospital Progress note | |
| 100608-9 | | Orthotics prosthetics Hospital Progress note | |
| 100609-7 | | Otolaryngology Hospital Progress note | |
| 10061-0 | | S' wave amplitude in lead I | |
| 100610-5 | | Pain medicine Hospital Progress note | |
| 100611-3 | | Palliative care Hospital Progress note | |
| 100612-1 | | Pastoral care Hospital Progress note | |
| 100613-9 | | Pediatric cardiology Hospital Progress note | |
| 100614-7 | | Pediatric dermatology Hospital Progress note | |
| 100615-4 | | Pediatric endocrinology Hospital Progress note | |
| 100616-2 | | Pediatric gastroenterology Hospital Progress note | |
| 100617-0 | | Pediatric hematology-oncology Hospital Progress note | |
| 100618-8 | | Pediatric infectious diseases Hospital Progress note | |
| 100619-6 | | Pediatric otolaryngology Hospital Progress note | |
| 10062-8 | | S' wave amplitude in lead II | |
| 100620-4 | | Pediatric pulmonology Hospital Progress note | |
| 100621-2 | | Pediatric rheumatology Hospital Progress note | |
| 100622-0 | | Pediatric surgery Hospital Progress note | |
| 100623-8 | | Pediatric transplant hepatology Hospital Progress note | |
| 100624-6 | | Pharmacogenomics Hospital Progress note | |
| 100625-3 | | Pharmacology Hospital Progress note | |
| 100626-1 | | Physical medicine and rehab Hospital Progress note | |
| 100627-9 | | Physical therapy Hospital Progress note | |
| 100628-7 | | Plastic surgery Hospital Progress note | |
| 100629-5 | | Podiatry Hospital Progress note | |
| 10063-6 | | S' wave amplitude in lead III | |
| 100630-3 | | Psychology Hospital Progress note | |
| 100631-1 | | Radiation oncology Hospital Progress note | |
| 100632-9 | | Radiology Hospital Progress note | |
| 100633-7 | | Rapid response team Hospital Progress note | |
| 100634-5 | | Recreational therapy Hospital Progress note | |
| 100635-2 | | Reproductive endocrinology and infertility Hospital Progress note | |
| 100636-0 | | Research Hospital Progress note | |
| 100637-8 | | Rheumatology Hospital Progress note | |
| 100638-6 | | Sleep medicine Hospital Progress note | |
| 100639-4 | | Social worker Hospital Progress note | |
| 10064-4 | | S' wave amplitude in lead V1 | |
| 100640-2 | | Solid Organ Transplant Hospital Progress note | |
| 100641-0 | | Speech-language pathology Hospital Progress note | |
| 100642-8 | | Spinal surgery Hospital Progress note | |
| 100643-6 | | Surgery of the hand Hospital Progress note | |
| 100644-4 | | Thromboembolism Hospital Progress note | |
| 100645-1 | | Trauma Hospital Progress note | |
| 100646-9 | | Urology Hospital Progress note | |
| 100647-7 | | Vascular neurology Hospital Progress note | |
| 100648-5 | | Vascular surgery Hospital Progress note | |
| 100649-3 | | Wound care management Hospital Progress note | |
| 10065-1 | | S' wave amplitude in lead V2 | |
| 100650-1 | | Wound, Ostomy, and Continence Care Hospital Progress note | |
| 100651-9 | | Hospital COVID-19 Intubation Progress note | |
| 100652-7 | | Pure tone bone conduction threshold audiometry panel | |
| 100653-5 | | Pure tone air conduction threshold audiometry panel | |
| 100654-3 | | Pyruvate kinase M2 [Presence] in Stool | |
| 100655-0 | | XR Sella turcica Lateral | |
| 100656-8 | | Maternal and fetal medicine Outpatient Progress note | |
| 100657-6 | | Maternal and fetal medicine Telephone encounter+Hospital Progress note | |
| 100658-4 | | Hospital COVID-19 Progress note | |
| 100659-2 | | Maternal and fetal medicine Hospital Progress note | |
| 10066-9 | | S' wave amplitude in lead V3 | |
| 100660-0 | | Maternal and fetal medicine Telephone encounter+Outpatient Progress note | |
| 100661-8 | | Psychiatry Outpatient Progress note | |
| 100662-6 | | Cortisol free and total panel - Serum or Plasma | |
| 100663-4 | | TPMT gene c.460G>A and c.719A>G [Presence] in Blood by Molecular genetics method | |
| 100664-2 | | NUDT15 gene c.50_55dup and c.415C>T [Presence] in Blood by Molecular genetics method | |
| 100665-9 | | NUDT15 gene c.415C>T [Presence] in Blood by Molecular genetics method | |
| 100666-7 | | NUDT15 gene c.416G>A [Presence] in Blood by Molecular genetics method | |
| 100667-5 | | NUDT15 gene c.52G>A [Presence] in Blood by Molecular genetics method | |
| 100668-3 | | NUDT15 gene c.50_55dup [Presence] in Blood by Molecular genetics method | |
| 100669-1 | | NUDT15 gene c.50_55del [Presence] in Blood by Molecular genetics method | |
| 10067-7 | | S' wave amplitude in lead V4 | |
| 100670-9 | | RHD gene allele [Identifier] in Plasma cell-free DNA Nominal--fetus | |
| 100671-7 | | Aspergillus sp DNA [Presence] in Blood by NAA with probe detection | |
| 100672-5 | | Aspergillus fumigatus DNA [Presence] in Blood by NAA with probe detection | |
| 100673-3 | | Aspergillus terreus DNA [Presence] in Blood by NAA with probe detection | |
| 100674-1 | | BK virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | |
| 100675-8 | | Cytomegalovirus DNA [Units/volume] (viral load) in Blood by NAA with probe detection | |
| 100676-6 | | Cytomegalovirus DNA [log units/volume] (viral load) in Blood by NAA with probe detection | |
| 100677-4 | | Epstein Barr virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | |
| 100678-2 | | Epstein Barr virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | |
| 100679-0 | | Herpes virus 6 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | |
| 10068-5 | | S' wave amplitude in lead V5 | |
| 100680-8 | | Herpes virus 6 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | |
| 100681-6 | | Herpes virus 7 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | |
| 100682-4 | | Herpes virus 7 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | |
| 100683-2 | | Herpes virus 8 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | |
| 100684-0 | | Herpes virus 8 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | |
| 100685-7 | | JC virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | |
| 100686-5 | | JC virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | |
| 100687-3 | | JC virus DNA [Log #/volume] (viral load) in Urine by NAA with probe detection | |
| 100688-1 | | Parvovirus B19 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | |
| 100689-9 | | Toxoplasma gondii DNA [Log #/volume] in Serum or Plasma by NAA with probe detection | |
| 10069-3 | | S' wave amplitude in lead V6 | |
| 100690-7 | | Toxoplasma gondii DNA [Log #/volume] in Cerebral spinal fluid by NAA with probe detection | |
| 100691-5 | | Varicella zoster virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | |
| 100692-3 | | Varicella zoster virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | |
| 100693-1 | | Pneumocystis jiroveci DNA [Log #/volume] in Respiratory specimen by NAA with probe detection | |
| 100694-9 | | SMN1 gene silent carrier analysis [Presence] in Blood or Tissue by Molecular genetics method | |
| 100695-6 | | Genetic disease analysis overall carrier interpretation in Blood or Tissue by Molecular genetics method Narrative | |
| 100696-4 | | CTNS related multigene analysis [Identifier] in Bodyfluid and Serum or Plasma by Molecular genetics method Nominal | |
| 100697-2 | | Interventional radiology Outpatient Note | |
| 100698-0 | | Social Determinants of Health screening report Document | |
| 100699-8 | | Rifabutin+Ethambutol [Susceptibility] | |
| 1007-4 | | Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells | |
| 10070-1 | | S' wave duration in lead AVF | |
| 100700-4 | | Trichomonas vaginalis DNA [Presence] in Urethra by NAA with probe detection | |
| 100701-2 | | Trichomonas vaginalis rRNA [Presence] in Urethra by NAA with probe detection | |
| 100702-0 | | Mycoplasma genitalium rRNA [Presence] in Urethra by NAA with probe detection | |
| 100703-8 | | Mycoplasma genitalium rRNA [Presence] in Urine by NAA with probe detection | |
| 100704-6 | | Mycoplasma genitalium rRNA [Presence] in Cervix by NAA with probe detection | |
| 100705-3 | | Mycoplasma genitalium rRNA [Presence] in Anorectal by NAA with probe detection | |
| 100706-1 | | Mycoplasma genitalium rRNA [Presence] in Specimen by NAA with probe detection | |
| 100707-9 | | Polymorphonuclear cells [#/volume] in Peritoneal dialysis fluid by Automated count | |
| 100708-7 | | Plasma cells/100 leukocytes in Synovial fluid | |
| 100709-5 | | Hepatocellular carcinoma risk [Score] by GAAD | |
| 10071-9 | | S' wave duration in lead AVL | |
| 100710-3 | | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Throat by NAA with probe detection | |
| 100711-1 | | Borrelia burgdorferi.VlsE1+pepC10 Ab [Units/volume] in Serum by Immunoassay | |
| 100712-9 | | Brexpiprazole [Mass/volume] in Serum or Plasma | |
| 100713-7 | | Cariprazine [Mass/volume] in Serum or Plasma | |
| 100714-5 | | Guanfacine [Mass/volume] in Serum or Plasma | |
| 100715-2 | | Prothipendyl [Mass/volume] in Serum or Plasma | |
| 100716-0 | | Prostate specific Ag [Mass/volume] in DBS | |
| 100717-8 | | FCGR3A gene.p.Phe176Val [Presence] in Blood or Tissue by Molecular genetics method | |
| 100718-6 | | Undersea and hyperbaric medicine Discharge summary | |
| 100719-4 | | Surgical oncology Discharge summary | |
| 10072-7 | | S' wave duration in lead AVR | |
| 100720-2 | | Reproductive endocrinology and infertility Discharge summary | |
| 100721-0 | | Community health care Discharge summary | |
| 100722-8 | | Integrative medicine Discharge summary | |
| 100723-6 | | Sports medicine Discharge summary | |
| 100724-4 | | Diabetology Discharge summary | |
| 100725-1 | | Optometry Discharge summary | |
| 100726-9 | | Podiatry Discharge summary | |
| 100727-7 | | Chiropractic medicine Discharge summary | |
| 100728-5 | | Cardiac surgery Discharge summary | |
| 100729-3 | | Breastfeeding Discharge summary | |
| 10073-5 | | S' wave duration in lead I | |
| 100730-1 | | Transplant surgery Discharge summary | |
| 100731-9 | | Urgent care center Discharge summary | |
| 100732-7 | | Cholesterol.in lipoprotein (little a) and Cholesterol.in LDL panel - Serum | |
| 100733-5 | | Cholesterol in LDL [Mass/volume] in Serum by calculation --corrected for Cholesterol.in lipoprotein (little a) | |
| 100734-3 | | traMADol and Metabolites Panel - Urine by Confirmatory method | |
| 100735-0 | | Mannose-6-phosphate isomerase and phosphomannomutase 1 panel - Leukocytes | |
| 100736-8 | | Acylcarnitine Analysis Post Mortem in Specimen Document | |
| 100737-6 | | Alkaline phosphatase.macromolecular [Presence] in Serum or Plasma | |
| 100738-4 | | Alanine aminotransferase.macromolecular [Presence] in Serum or Plasma | |
| 100739-2 | | Aspartate aminotransferase.macromolecular [Presence] in Serum or Plasma | |
| 10074-3 | | S' wave duration in lead II | |
| 100740-0 | | Amylase.macromolecular [Presence] in Serum or Plasma | |
| 100741-8 | | Gamma glutamyl transferase.macromolecular [Presence] in Serum or Plasma | |
| 100742-6 | | Lactate dehydrogenase.macromolecular [Presence] in Serum or Plasma | |
| 100743-4 | | Lipase.macromolecular [Presence] in Serum or Plasma | |
| 100744-2 | | Alpha-1-acid glycoprotein [Mass/volume] in Serum or Plasma by Electrophoresis | |
| 100745-9 | | Chloride [Moles/volume] in Mixed venous blood | |
| 100746-7 | | Glucose [Moles/volume] in Mixed venous blood | |
| 100747-5 | | Legionella serogroup panel - Specimen | |
| 100748-3 | | Legionella spp [Presence] in Specimen by NAA with probe detection | |
| 100749-1 | | Legionella pneumophila serogroup 1 [Presence] in Specimen by NAA with probe detection | |
| 10075-0 | | S' wave duration in lead III | |
| 100750-9 | | Legionella pneumophila non-serogroup 1 [Presence] in Specimen by NAA with probe detection | |
| 100751-7 | | Galactose-alpha-1,3-galactose (Alpha-Gal) panel - Serum or Plasma | |
| 100752-5 | | Exacerbating factors - Reported | |
| 100753-3 | | Alleviating factors - Reported | |
| 100754-1 | | Platelet disorders multigene analysis in Blood or Tissue by Sequencing | |
| 100755-8 | | Oligoclonal bands [#] in Serum or Plasma by Isoelectric focusing | |
| 100756-6 | | Oligoclonal bands [Interpretation] in Cerebral spinal fluid by Isoelectric focusing | |
| 100757-4 | | Protein fractions.oligoclonal bands panel - Serum and CSF by Isoelectric focusing | |
| 100758-2 | | Estimated lung age by based on clinical data | |
| 100759-0 | | Inspiratory reserve [Volume] Respiratory system by Spirometry | |
| 10076-8 | | S' wave duration in lead V1 | |
| 100760-8 | | XR Radius and Ulna - left Single view | |
| 100761-6 | | PALB2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | |
| 100762-4 | | HBA2 gene.c.377T>C [Presence] in Blood by Molecular genetics method | |
| 100763-2 | | Mycobacterium sp comparative reaction interpretation Narrative | |
| 100764-0 | | Mycobacterium bovis reaction wheal [Diameter] Qualitative --3 days post dose mammalian tuberculin intradermal | |
| 100765-7 | | Homocysteine and methylmalonate and methylcitrate panel - DBS | |
| 10077-6 | | S' wave duration in lead V2 | |
| 10078-4 | | S' wave duration in lead V3 | |
| 100788-9 | | Stemphylium botryosum IgG4 Ab [Mass/volume] in Serum | |
| 100789-7 | | Rhizopus nigricans IgG4 Ab [Mass/volume] in Serum | |
| 10079-2 | | S' wave duration in lead V4 | |
| 100790-5 | | Lepidoglyphus destructor IgG Ab [Mass/volume] in Serum | |
| 100791-3 | | Hamster epithelium IgG Ab [Mass/volume] in Serum | |
| 100792-1 | | Forsythia IgE Ab [Units/volume] in Serum | |
| 100793-9 | | Testosterone [Mass/volume] in Body fluid | |
| 100794-7 | | Follitropin [Units/volume] in Body fluid | |
| 100795-4 | | S100 calcium binding protein B [Mass/volume] in Body fluid | |
| 100796-2 | | Thyroglobulin [Mass/volume] in Body fluid | |
| 100797-0 | | Testosterone Free [Mass/volume] in Serum --1st specimen post XXX challenge | |
| 100798-8 | | Testosterone Free [Mass/volume] in Serum --2nd specimen post XXX challenge | |
| 100799-6 | | 21-Deoxycortisol [Mass/volume] in Serum --1st specimen post XXX challenge | |
| 1008-2 | | Indirect antiglobulin test.polyspecific reagent [Presence] in Serum or Plasma | |
| 10080-0 | | S' wave duration in lead V5 | |
| 100800-2 | | 21-Deoxycortisol [Mass/volume] in Serum --2nd specimen post XXX challenge | |
| 100801-0 | | 21-Deoxycortisol [Mass/volume] in Serum --3rd specimen post XXX challenge | |
| 100802-8 | | 21-Deoxycortisol [Mass/volume] in Serum --4th specimen post XXX challenge | |
| 100803-6 | | 21-Deoxycortisol [Mass/volume] in Serum --5th specimen post XXX challenge | |
| 100804-4 | | Vasopressin [Moles/volume] in Plasma --1st specimen post XXX challenge | |
| 100805-1 | | Vasopressin [Moles/volume] in Plasma --2nd specimen post XXX challenge | |
| 100806-9 | | Vasopressin [Moles/volume] in Plasma --3rd specimen post XXX challenge | |
| 100807-7 | | Vasopressin [Moles/volume] in Plasma --4th specimen post XXX challenge | |
| 100808-5 | | Vasopressin [Moles/volume] in Plasma --5th specimen post XXX challenge | |
| 100809-3 | | Vasopressin [Moles/volume] in Plasma --6th specimen post XXX challenge | |
| 10081-8 | | S' wave duration in lead V6 | |
| 100810-1 | | Vasopressin [Moles/volume] in Plasma --7th specimen post XXX challenge | |
| 100811-9 | | Vasopressin [Moles/volume] in Plasma --8th specimen post XXX challenge | |
| 100812-7 | | Vasopressin [Moles/volume] in Plasma --9th specimen post XXX challenge | |
| 100813-5 | | Vasopressin [Moles/volume] in Plasma --10th specimen post XXX challenge | |
| 100814-3 | | Vasopressin [Moles/volume] in Plasma --11th specimen post XXX challenge | |
| 100815-0 | | Vasopressin [Moles/volume] in Plasma --12th specimen post XXX challenge | |
| 100816-8 | | Glucagon [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge | |
| 100817-6 | | Glucagon [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge | |
| 100818-4 | | Renin [Mass/volume] in Plasma --1st specimen post XXX challenge | |
| 100819-2 | | Renin [Mass/volume] in Plasma --2nd specimen post XXX challenge | |
| 10082-6 | | ST initial amplitude 6 ms in lead AVF | |
| 100820-0 | | Renin [Mass/volume] in Plasma --3rd specimen post XXX challenge | |
| 100821-8 | | National POLST form: portable medical order panel | |
| 100822-6 | | Cardiopulmonary resuscitation orders | |
| 100823-4 | | Initial portable medical treatment orders | |
| 100824-2 | | Additional portable medical orders or instructions | |
| 100825-9 | | Medically assisted nutrition orders | |
| 100826-7 | | Portable medical order AndOr advance directive review | |
| 100827-5 | | Portable medical order discussion participants | |
| 100828-3 | | Portable medical order administrative information | |
| 100829-1 | | Renin [Mass/volume] in Plasma --4th specimen post XXX challenge | |
| 10083-4 | | ST initial amplitude 6 ms in lead AVL | |
| 100830-9 | | Alpha subunit free [Units/volume] in Serum or Plasma --1st specimen post XXX challenge | |
| 100831-7 | | Alpha subunit free [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge | |
| 100832-5 | | Alpha subunit free [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge | |
| 100833-3 | | Alpha subunit free [Units/volume] in Serum or Plasma --4th specimen post XXX challenge | |
| 100834-1 | | Alpha subunit free [Units/volume] in Serum or Plasma --5th specimen post XXX challenge | |
| 100835-8 | | Alpha subunit free [Units/volume] in Serum or Plasma --6th specimen post XXX challenge | |
| 100836-6 | | Alpha subunit free [Units/volume] in Serum or Plasma --7th specimen post XXX challenge | |
| 100837-4 | | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge | |
| 100838-2 | | Testosterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge | |
| 100839-0 | | Vitamin A/Retinol binding protein [Ratio] in Serum or Plasma | |
| 10084-2 | | ST initial amplitude 6 ms in lead AVR | |
| 100840-8 | | IgE [Units/volume] in Body fluid | |
| 100841-6 | | Zinc finger protein of the cerebellum 4 Ab [Presence] in Cerebral spinal fluid by Line blot | |
| 100842-4 | | Nonalcoholic steatohepatitis score in Serum or Plasma Calculated by FAST | |
| 100843-2 | | Liver fibrosis score in Serum or Plasma by Calculated.Agile3+ | |
| 100844-0 | | Liver fibrosis score in Serum or Plasma by Calculated.Agile4 | |
| 100845-7 | | Neurofascin155 IgG4 Ab [Presence] in Serum by Flow cytometry (FC) | |
| 100846-5 | | Dengue virus 1+2+3+4 nsP1 IgG Ab [Presence] in Serum or Plasma by Immunoassay | |
| 100847-3 | | Gas and ammonia panel - Arterial blood | |
| 100848-1 | | Cell count and Differential panel - Amniotic fluid by Manual count | |
| 100849-9 | | Leukocytes [#/volume] in Amniotic fluid by Manual count | |
| 10085-9 | | ST initial amplitude 6 ms in lead I | |
| 100850-7 | | Neutrophils [#/volume] in Amniotic fluid by Manual count | |
| 100851-5 | | Other cells [#/volume] in Amniotic fluid by Manual count | |
| 100852-3 | | NM Bones Views for metastasis W Sr-89 IV | |
| 100853-1 | | NM Pericardial space Pericardial effusion | |
| 100854-9 | | Lymphocytes/100 cells in Blood mononuclear cells by Immunoassay | |
| 100855-6 | | CD3 cells/100 cells in Blood mononuclear cells | |
| 100856-4 | | CD3+CD4+ (T4 helper) cells/100 cells in Blood mononuclear cells | |
| 100857-2 | | CD3+CD8+ (T8 suppressor) cells/100 cells in Blood mononuclear cells | |
| 100858-0 | | Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide | |
| 100859-8 | | Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide | |
| 10086-7 | | ST initial amplitude 6 ms in lead II | |
| 100860-6 | | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide | |
| 100861-4 | | Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | |
| 100862-2 | | Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | |
| 100863-0 | | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | |
| 100864-8 | | Giardia lamblia bg gene [Genotype] in Specimen by Molecular genetics method | |
| 100865-5 | | Avian schistosomes DNA [Presence] in Specimen by NAA with probe detection | |
| 100866-3 | | Febrile antibody profile in Serum | |
| 100867-1 | | Campylobacter jejuni+coli+lari+upsaliensis Ag [Presence] in Stool by Rapid immunoassay | |
| 100868-9 | | Cryptosporidium sp 18S-LC2 rRNA [Genotype] in Specimen by Molecular genetics method | |
| 100869-7 | | Cryptosporidium gp60 gene [Type] in Specimen by Molecular genetics method | |
| 10087-5 | | ST initial amplitude 6 ms in lead III | |
| 100870-5 | | Cryptosporidium 18S rRNA [Genotype] in Specimen by Molecular genetics method | |
| 100871-3 | | Giardia lamblia gdh gene [Genotype] in Specimen by Molecular genetics method | |
| 100872-1 | | Bacteria producing polysaccharide from sucrose [Presence] in Isolate | |
| 100873-9 | | Giardia lamblia tpi gene [Genotype] in Specimen by Molecular genetics method | |
| 100874-7 | | Basidiobolus sp [Presence] in Specimen | |
| 100875-4 | | Fetal Heart Document limited US | |
| 100876-2 | | Fetal Heart Document US | |
| 100877-0 | | US Heart Transesophageal during surgery | |
| 100878-8 | | Endoscopic ultrasound study Upper GI tract Document | |
| 100879-6 | | US Guidance for cryoablation of Breast - right | |
| 10088-3 | | ST initial amplitude 6 ms in lead V1 | |
| 100880-4 | | US Guidance for cryoablation of Breast - left | |
| 100881-2 | | MR Guidance for cryoablation of Bone | |
| 100882-0 | | MR Peritoneum W contrast percutaneous intraperitoneal | |
| 100883-8 | | MR Guidance for biopsy of Kidney - left | |
| 100884-6 | | MR Guidance for biopsy of Kidney - right | |
| 100885-3 | | Parapoxvirus DNA [Presence] in Specimen by NAA with probe detection | |
| 100886-1 | | Orf virus DNA [Presence] in Specimen by NAA with probe detection | |
| 100887-9 | | Pseudocowpox virus DNA [Presence] in Specimen by NAA with probe detection | |
| 100888-7 | | Monkeypox virus clade II DNA [Presence] in Specimen by NAA with probe detection | |
| 100889-5 | | Monkeypox virus clade I DNA [Presence] in Specimen by NAA with probe detection | |
| 10089-1 | | ST initial amplitude 6 ms in lead V2 | |
| 100890-3 | | Poxvirus DNA panel | |
| 100891-1 | | Orthopoxvirus IgG Ab [Presence] in Serum or Plasma by Immunoassay | |
| 100892-9 | | Orthopoxvirus IgM Ab [Presence] in Serum or Plasma by Immunoassay | |
| 100893-7 | | Orthopoxvirus IgG and IgM Ab panel - Serum or Plasma | |
| 100894-5 | | Recommended screening frequency Narrative | |
| 100895-2 | | Rickettsia conorii IgG and IgM [Interpretation] in Serum | |
| 100896-0 | | Vasopressin [Moles/volume] in Plasma --13th specimen post XXX challenge | |
| 100897-8 | | Staphylococcus aureus [Presence] in Specimen by Organism specific culture | |
jurisdiction[0]